Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ANKRD34C		ENSG00000235711	"Ankyrin repeat domain 34C"	P0C6C1	15	79293285-79298235	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"brain: 5.5"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 3.0;Inhibitory neurons: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"SCLC-21H: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045329			Approved	Mitochondria		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA045329: AB_2679291"	"unprognostic (3.20e-1)"			"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"						"unprognostic (1.81e-1)"		"unprognostic (3.42e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.48e-1)"			0.1	0.1	1.4	0.0	0.5	0.0	0.0	2.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	3.0	0.0	0.0	0.1	0.0	2.2	2.8	0.0	0.2	0.0	0.7	0.0	3.4	0.0	0.0	0.5	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	2.0	1.9	0.4	3.0	2.2	2.8	3.4	0.2	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 85.6"	"Lineage enriched"	"Detected in all"	5	"T-cells: 85.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"HPA038521: AB_2676058, HPA038522: AB_2676059"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	18.1	23.8	101.7	11.9	119.4	2.7	18.0	116.6	121.1	39.5	65.1	43.3	7.0	43.5	4.3	14.9	38.3	11.4	42.0	123.3	105.3	21.5	3.8	22.5	13.9	123.9	106.0	39.2	16.3	21.4	61.3	8.6	135.0	23.7	4.7	23.3	13.4	25.9	42.3	12.2	19.2	33.2	109.4	13.8	19.4	12.7	112.1	28.9	19.1	54.0	11.1	31.2	23.5	152.9	0.0	14.9	50.6	22.8	26.7	27.4	0.2	24.6	41.7	41.2	51.4	26.4	10.3	0.0	3.6	44.3	36.9	0.5	44.4	7.5	19.4	27.8	33.7	0.3	9.3	0.9	19.3	0.2	9.9	24.8	1.9	19.4	2.9	35.3	51.7	1.2	1.1	0.7	15.3	0.5	0.5	0.1	18.3	0.8	15.5	0.2	2.0	0.2	1.7	0.2	68.1	37.6	3.6	3.0	15.9	15.2	2.1	3.4	22.8	4.2	24.8	27.5	5.0	13.8	6.8	2.0	21.1	0.0	14.3	8.4	1.7	0.3	23.2	1.5	25.2	6.7	32.5	30.2	1.7	16.2	85.6	51.7	1.6	16.5	0.6	0.3	48.7	29.9	101.7	119.4	116.6	121.1	123.3	105.3	123.9	106.0	135.0	109.4	112.1	152.9	9.6	19.2	5.4	22.9	7.5	5.0	12.1	3.6	12.0	45.8	6.6	5.7	50.5	11.5	5.4	5.5	22.9	0.4	4.6	1.1	25.4	18.2	5.6	7.6	9.5	13.9	19.3	4.0	47.1	4.2	0.7	15.2	4.6	2.3	1.3	10.8	15.7	3.3	1.2	40.4	44.8	1.2	0.0	1.9	4.0	13.1	9.6	1.8	8.8	7.5	3.2	24.7	9.2	49.3	102.3	8.0	1.7	19.2	1.4	8.3	0.4	21.6	17.3	20.1	6.6	10.0	17.3	6.9	13.7	3.2	2.8	0.8	20.1	7.0	1.3	5.4
ARHGAP44	"KIAA0672, RICH-2, RICH2"	ENSG00000006740	"Rho GTPase activating protein 44"	Q17R89	17	12789498-12991643	"Predicted intracellular proteins"	Exocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 205.3;Horizontal cells: 178.4;Inhibitory neurons: 189.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.5;JURKAT: 5.9;SK-BR-3: 7.2;SuSa: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038814	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038814: AB_10673295"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.95e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.98e-1)"	"unprognostic (9.58e-2)"	4.4	1.7	14.7	2.2	12.6	0.0	2.0	2.8	35.2	2.7	0.0	15.3	7.2	2.9	3.1	0.8	9.8	5.4	4.2	19.2	5.7	2.5	0.6	12.0	1.5	11.5	6.7	4.0	3.6	17.4	8.1	9.4	9.1	3.1	12.0	7.0	5.7	4.0	2.3	1.4	7.5	3.0	0.5	0.7	3.3	2.7	15.2	0.7	6.4	2.5	1.6	2.1	2.2	19.3	0.3	1.5	1.2	0.9	0.1	0.6	4.0	0.6	4.8	0.2	0.5	0.6	0.2	3.8	0.4	1.6	2.4	0.5	2.6	0.0	0.1	0.0	9.5	0.0	1.4	1.5	0.1	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.0	5.9	0.2	0.0	0.0	4.7	0.4	0.0	3.7	2.1	0.2	3.4	0.0	0.9	0.0	1.3	3.8	0.2	0.2	7.2	0.0	12.1	0.8	1.4	0.0	3.7	1.9	1.3	0.0	0.0	0.0	0.4	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	12.6	2.8	35.2	19.2	5.7	11.5	6.7	9.1	0.5	15.2	19.3	1.4	12.8	12.8	25.8	2.4	2.7	4.8	2.1	1.8	23.1	3.2	2.7	8.7	15.7	2.3	9.2	2.1	2.1	0.2	32.4	0.0	4.8	14.3	8.9	2.2	2.8	12.0	0.8	205.3	4.6	1.2	6.3	3.1	4.2	0.0	5.4	4.6	0.6	0.6	178.4	189.4	15.4	2.0	0.6	1.2	3.4	4.4	0.3	1.8	10.3	0.1	5.4	1.0	38.7	19.0	3.4	14.3	10.9	1.2	4.2	7.4	0.6	8.6	14.7	19.7	3.8	12.4	0.8	7.1	1.6	1.6	0.8	0.9	2.5	32.8	3.2
ASXL3	KIAA1713	ENSG00000141431	"ASXL transcriptional regulator 3"	Q9C0F0	18	33578219-33751195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 2.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 52.5;Excitatory neurons: 125.1;Inhibitory neurons: 101.1;Late spermatids: 31.6;Oligodendrocyte precursor cells: 88.4;Oligodendrocytes: 62.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;RPMI-8226: 7.4;SCLC-21H: 2.8;SH-SY5Y: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039539, HPA040034"	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039539: , HPA040034: "	"unprognostic (2.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.73e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.47e-12)"	"unprognostic (4.69e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.67e-2)"	0.2	0.0	1.7	0.0	1.4	0.0	0.2	0.0	1.9	0.7	0.1	0.6	0.2	0.3	0.3	0.0	0.5	0.4	0.5	1.5	0.7	0.6	0.4	0.2	0.0	0.4	0.2	2.2	0.3	0.2	0.7	0.0	0.1	0.6	0.1	0.5	0.2	0.6	0.0	0.1	0.3	0.2	0.1	0.1	0.8	1.6	0.1	0.0	0.9	0.0	0.0	0.5	0.4	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	2.8	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	1.9	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.7	1.0	0.0	0.0	11.1	0.0	0.1	1.0	0.0	1.2	5.3	0.2	0.9	4.8	1.5	3.1	1.8	0.0	0.6	0.0	1.0	1.9	1.7	52.5	0.1	1.5	0.4	3.0	0.0	125.1	0.0	0.2	3.2	3.1	0.1	1.3	0.0	0.4	2.0	0.2	1.7	101.1	0.7	0.0	0.0	0.0	31.6	2.1	0.1	0.0	10.3	0.0	1.0	0.0	88.4	62.2	0.4	0.4	1.9	0.0	0.4	1.5	1.2	0.0	0.9	0.0	1.1	2.6	2.9	3.7	0.2	0.0	0.4	0.0	11.2	0.6	0.3
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 101.5;salivary gland: 185.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 82.5;Distal enterocytes: 120.7;Enteroendocrine cells: 97.8;Gastric mucus-secreting cells: 153.4;Intestinal goblet cells: 128.4;Plasma cells: 96.0;Undifferentiated cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 186.8;HMC-1: 266.1;JURKAT: 152.1;MOLT-4: 253.2;SK-BR-3: 195.2"	"Region enriched"	"Detected in all"	15	"cerebellum: 67.2"	"Low region specificity"	"Detected in all"			"HPA007180, CAB010882"	Approved					NA	NA		5400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	6.8	13.7	6.8	62.2	8.7	98.3	7.7	20.0	6.1	6.0	15.3	55.0	30.7	9.1	1.6	9.7	6.1	13.7	8.0	3.0	4.5	11.4	4.6	22.4	101.5	2.3	12.8	3.1	64.0	2.1	2.5	2.8	3.9	20.3	33.0	0.2	185.3	19.6	3.3	28.2	75.3	6.3	2.0	98.2	92.8	2.1	11.6	97.5	11.7	3.3	58.7	17.0	7.2	2.3	0.3	7.6	0.3	6.8	0.0	0.0	0.3	0.4	0.9	0.2	0.6	2.5	1.7	186.8	11.0	0.6	0.1	0.8	3.1	0.0	0.0	23.5	2.1	98.0	6.0	0.1	1.7	108.0	266.1	0.2	0.0	0.7	0.0	0.1	0.3	152.1	20.1	117.1	0.1	116.8	253.2	115.5	1.2	53.1	1.6	27.5	0.2	43.3	0.0	3.3	11.5	3.4	1.5	195.2	0.2	1.1	12.2	26.3	0.5	0.0	2.1	0.4	0.1	43.4	14.2	66.0	2.5	75.6	0.1	16.0	1.4	33.7	10.8	0.9	8.3	9.8	6.7	10.3	1.6	11.4	4.8	6.0	13.1	3.8	0.5	15.8	6.4	6.7	6.8	8.7	20.0	6.1	3.0	4.5	2.3	12.8	3.9	2.0	11.6	2.3	7.1	0.0	1.9	0.7	82.5	0.9	0.4	0.7	1.2	0.0	4.7	1.7	3.8	2.8	2.7	23.9	0.0	0.2	59.2	120.7	0.0	1.3	0.1	0.3	0.4	7.8	97.8	22.5	0.5	12.1	0.3	1.9	153.4	0.3	33.0	0.2	8.9	1.0	2.8	0.0	0.6	128.4	36.7	3.1	2.5	0.2	0.0	17.8	12.4	5.6	5.0	0.2	28.8	0.0	0.3	25.2	50.3	0.7	96.0	4.2	14.0	0.4	2.7	0.2	0.0	1.0	3.4	0.0	1.5	0.4	0.3	0.0	38.4	0.4	65.6	4.6
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623409-57633239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 61.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.0;Excitatory neurons: 22.0;Horizontal cells: 21.9;Inhibitory neurons: 13.4;Smooth muscle cells: 7.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		35000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	1.9	1.1	26.9	1.9	29.7	0.0	0.7	29.3	61.1	1.3	0.6	2.7	0.5	2.1	2.7	0.7	0.7	1.1	3.3	34.9	21.9	0.8	0.4	0.6	0.6	16.7	11.8	0.3	0.3	0.3	1.7	0.4	20.5	2.6	1.2	4.2	1.8	5.0	9.5	0.6	1.2	2.5	8.1	0.6	0.9	0.7	19.1	0.3	1.2	7.2	1.0	1.2	1.6	29.9	7.5	38.2	18.2	38.7	0.3	0.1	0.4	3.0	11.3	19.0	17.5	2.8	21.9	3.0	47.9	13.2	35.9	3.3	15.3	2.1	5.2	67.4	2.6	1.8	10.1	9.9	0.4	3.1	4.1	0.1	0.9	11.0	0.5	6.7	0.2	11.4	8.7	34.8	2.4	13.5	2.5	0.1	13.0	0.9	7.7	0.1	27.1	8.0	0.1	0.1	34.9	12.3	3.1	1.1	0.4	0.9	7.0	3.3	0.0	22.8	28.1	24.0	26.1	37.0	34.0	2.6	28.9	2.3	45.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.9	29.7	29.3	61.1	34.9	21.9	16.7	11.8	20.5	8.1	19.1	29.9	0.8	0.0	0.0	2.6	0.0	0.4	0.0	0.0	0.0	10.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.0	0.8	0.0	0.0	22.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	21.9	13.4	0.0	0.0	0.0	0.3	0.7	2.8	0.1	3.6	2.8	2.6	0.7	0.0	4.5	2.7	0.5	0.0	3.0	0.0	0.1	0.0	0.2	0.0	2.6	6.6	0.6	7.5	1.6	4.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1
BAG2		ENSG00000112208	"BAG cochaperone 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.7	4.4	2.5	6.6	2.7	1.5	1.7	2.8	4.0	11.4	3.0	32.6	2.1	25.1	3.9	7.2	9.1	7.3	9.1	2.5	2.7	2.8	4.1	5.0	2.7	2.3	2.7	8.5	1.6	0.4	2.0	7.6	2.4	11.2	4.5	4.9	1.0	15.9	9.2	1.3	6.5	29.0	2.3	1.1	7.8	6.4	2.6	1.3	4.6	6.5	2.1	22.5	5.9	3.0	17.2	9.3	3.9	13.8	9.4	26.9	10.9	27.2	25.8	19.2	18.2	12.1	8.6	5.7	25.3	43.2	15.7	3.1	22.5	2.4	18.3	18.3	16.4	16.7	13.3	27.5	14.5	14.8	3.7	13.1	1.2	15.8	14.6	11.4	15.2	13.0	34.1	7.9	19.1	1.3	10.5	12.4	14.8	0.3	9.6	9.5	10.9	11.4	23.2	2.8	4.9	4.4	12.2	0.9	10.1	17.8	2.1	12.7	20.8	10.9	17.9	23.2	27.4	5.3	5.5	12.5	9.7	5.8	1.0	0.1	0.2	0.5	1.9	0.2	2.2	3.5	1.7	1.9	0.9	3.0	3.4	2.9	0.1	2.1	0.0	0.3	2.0	1.1	2.5	2.7	2.8	4.0	2.5	2.7	2.3	2.7	2.4	2.3	2.6	3.0	2.4	3.2	3.7	4.6	16.7	2.4	4.6	5.0	1.8	6.9	4.1	2.7	40.0	0.0	3.8	3.7	12.5	73.3	8.0	0.6	1.9	11.6	152.3	11.0	35.5	3.1	1.8	12.2	8.1	3.7	18.2	46.2	3.1	4.2	4.5	25.6	2.2	15.8	15.8	10.1	10.0	0.3	14.2	2.6	6.6	35.9	31.1	5.1	7.2	5.6	9.1	8.2	3.1	10.6	10.6	5.4	1.3	38.7	13.0	6.2	0.4	33.9	9.1	16.9	6.6	32.1	31.0	93.5	9.8	1.3	3.8	18.9	12.2	30.6	1.3	2.1
BRINP1	"DBC1, DBCCR1, FAM5A"	ENSG00000078725	"BMP/retinoic acid inducible neural specific 1"	O60477	9	119153458-119369435	"Predicted intracellular proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.5"	"Group enriched"	"Detected in some"	8	"Astrocytes: 178.9;Excitatory neurons: 285.7;Inhibitory neurons: 163.4;Oligodendrocyte precursor cells: 204.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 8.6;NTERA-2: 17.0;SCLC-21H: 7.4;SH-SY5Y: 3.2;SuSa: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038828	Approved		Uncertain	Microtubules	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules		"HPA038828: AB_10670909"	"unprognostic (8.60e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-4)"	"unprognostic (1.51e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	0.1	3.8	28.8	0.0	23.3	0.0	2.4	20.5	43.5	0.5	0.0	0.2	0.2	0.7	4.9	0.6	0.0	1.4	1.8	35.7	17.8	1.7	0.6	1.9	0.0	9.6	20.6	0.1	0.0	0.0	1.6	0.0	16.8	1.5	0.1	5.3	0.7	5.2	0.3	0.1	0.6	0.1	16.0	0.3	0.2	0.5	27.7	0.8	0.3	0.1	0.0	0.3	0.2	18.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	17.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	7.4	3.2	0.0	0.0	0.0	6.0	0.6	0.0	0.0	1.1	1.8	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	23.3	20.5	43.5	35.7	17.8	9.6	20.6	16.8	16.0	27.7	18.8	0.1	0.0	0.0	178.9	0.0	0.0	0.5	0.5	0.0	8.7	8.1	4.2	0.9	0.0	0.1	0.0	25.0	0.1	0.0	0.3	0.0	0.0	2.1	0.5	15.9	0.5	2.4	0.0	285.7	0.0	0.0	0.4	0.0	0.4	0.0	0.2	2.9	0.0	0.3	1.7	163.4	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	8.4	0.0	1.6	0.0	204.6	4.9	0.1	0.0	0.4	0.0	0.4	0.0	23.9	0.0	2.6	0.0	0.0	0.4	1.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.3
C12orf75	"AGD3, OCC-1, OCC1"	ENSG00000235162	"Chromosome 12 open reading frame 75"	Q8TAD7	12	105235290-105396097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 841.2;Ductal cells: 626.3;Endometrial ciliated cells: 579.1;Extravillous trophoblasts: 1228.2;Proximal tubular cells: 762.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 661.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 661.2;T-cells: 169.9"	"Cell line enhanced"	"Detected in all"		"BJ: 877.8;BJ hTERT+: 517.0;fHDF/TERT166: 432.7;RPTEC TERT1: 425.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065311	Uncertain		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA065311: AB_2685463"	"unprognostic (5.96e-2)"	"unprognostic (3.85e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.73e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (8.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.00e-2)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.47e-3)"	12.2	7.3	4.3	8.9	4.7	11.3	11.6	9.4	7.2	31.3	2.1	24.9	9.2	18.5	6.1	8.7	20.9	38.2	2.5	4.1	8.8	58.5	2.0	7.5	14.7	5.3	5.5	6.6	33.8	20.1	3.5	9.3	4.9	41.2	22.0	2.8	4.2	109.3	32.0	9.5	8.8	6.7	6.5	6.3	49.9	26.6	8.8	10.8	2.9	11.8	19.1	5.0	27.0	5.4	43.6	66.6	16.5	14.9	61.2	117.3	30.3	877.8	517.0	194.2	109.4	133.2	3.6	12.2	348.9	432.7	31.7	70.4	36.6	50.3	212.9	241.1	65.0	38.8	17.7	26.5	7.7	29.8	37.7	49.6	12.0	66.4	73.8	113.0	26.1	69.9	1.9	58.8	192.4	14.4	115.3	262.5	39.6	15.8	153.3	21.6	44.3	11.2	425.3	4.3	73.5	18.4	36.9	7.7	16.2	45.2	22.6	7.1	44.2	201.7	77.2	77.0	118.1	34.9	57.6	58.8	44.5	9.7	55.3	39.0	0.7	1.2	165.5	0.5	80.4	19.7	69.2	169.9	23.3	16.2	19.8	102.4	3.5	69.4	1.6	661.2	144.1	88.3	4.3	4.7	9.4	7.2	4.1	8.8	5.3	5.5	4.9	6.5	8.8	5.4	12.8	3.2	2.8	1.6	61.2	100.2	65.9	21.9	38.7	4.5	32.2	26.9	1.1	271.7	20.9	187.6	4.2	35.3	519.5	469.8	841.2	626.3	152.3	579.1	32.6	14.8	333.2	15.8	2.7	222.3	1228.2	53.0	160.5	293.1	2.5	9.7	13.2	1.8	31.9	63.9	2.9	63.6	85.5	5.3	97.3	324.1	15.5	48.2	60.5	40.3	29.1	6.4	299.7	0.5	0.4	420.0	175.5	4.9	160.3	87.0	102.1	762.3	129.7	4.9	6.6	8.6	127.8	102.9	118.6	37.1	61.2	40.6	143.0	0.7	63.9	37.3
CA11	"CARP2, CARPX1"	ENSG00000063180	"Carbonic anhydrase 11"	O75493	19	48637946-48646187	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 330.0;choroid plexus: 146.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 46.1;hTERT-RPE1: 47.1;SCLC-21H: 32.6;U-266/84: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041778			Approved	Vesicles,Microtubules	"Secreted in brain"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Microtubules"		"HPA041778: AB_10794525"	"unprognostic (1.39e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (2.59e-3)"	"unprognostic (5.72e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.80e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (2.11e-5)"	"unprognostic (3.79e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.75e-1)"	13.1	17.3	240.8	3.2	256.9	1.6	8.5	215.4	330.0	15.9	146.2	19.4	8.4	33.0	28.2	8.0	21.4	5.5	10.7	266.6	167.0	14.7	1.7	5.8	5.0	170.3	169.2	48.8	5.9	58.0	37.2	1.1	172.2	14.0	2.5	30.0	8.9	13.5	9.2	14.3	9.3	18.2	163.8	6.1	13.0	6.4	180.5	6.6	12.1	7.4	5.3	9.2	12.2	231.9	2.0	12.7	22.9	46.1	3.1	1.2	0.6	1.5	14.9	1.5	3.3	3.1	15.7	7.5	1.7	1.7	4.2	4.9	9.4	4.6	1.3	1.6	13.5	3.3	7.2	0.2	3.0	0.3	9.8	5.4	9.2	1.4	2.0	47.1	1.8	19.8	6.1	20.5	0.7	5.0	4.1	1.4	9.9	7.5	4.7	2.6	0.9	16.1	10.1	0.4	32.6	18.2	1.7	1.6	2.7	6.1	6.3	0.8	0.2	3.9	14.2	0.1	0.4	18.9	33.9	1.3	5.7	4.3	2.0	0.0	0.4	0.0	1.5	0.5	1.5	1.0	1.2	1.2	0.7	1.3	1.5	1.3	0.0	1.3	0.0	1.9	1.5	0.7	240.8	256.9	215.4	330.0	266.6	167.0	170.3	169.2	172.2	163.8	180.5	231.9	5.1	3.2	8.1	11.1	9.3	7.1	9.1	13.2	12.5	81.0	15.5	12.1	5.4	21.5	9.6	31.3	16.7	0.7	9.8	3.9	25.4	11.5	15.0	6.7	6.3	6.7	13.1	3.6	47.0	10.0	0.4	11.6	5.6	7.9	6.3	3.1	8.9	47.5	6.0	28.6	18.1	6.4	16.2	20.4	26.4	7.9	22.1	6.8	8.8	5.6	5.6	50.4	12.3	7.1	6.8	3.4	2.9	26.7	4.3	4.3	20.7	38.7	7.5	30.8	6.6	4.2	8.9	1.3	4.9	5.9	10.9	0.4	6.9	8.7	5.2	6.4
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CC2D2B	"bA248J23.4, bA690P14.3, C10orf130, C10orf131"	ENSG00000188649	"Coiled-coil and C2 domain containing 2B"	Q6DHV5	10	95907603-96033745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 8.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.8;Early spermatids: 10.8;Microglial cells: 15.0;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044091, HPA072122"	Enhanced		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"		"HPA044091: AB_2732514, HPA072122: AB_2686489"	"unprognostic (6.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.11e-3)"	"unprognostic (9.11e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.34e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-1)"	0.7	1.9	0.9	1.9	2.7	2.5	0.5	1.2	1.6	0.8	3.4	0.9	1.0	1.5	0.4	0.8	0.9	1.5	1.1	0.5	3.5	0.9	0.6	0.8	1.3	2.1	0.9	1.1	0.4	0.7	0.3	1.1	2.6	0.6	0.3	2.8	1.0	0.4	2.2	2.4	0.6	1.2	1.0	1.2	1.0	8.7	2.2	0.2	3.0	0.2	0.2	0.8	0.8	5.4	1.1	4.4	3.7	7.4	0.2	0.4	4.1	3.8	0.4	0.7	0.1	3.3	0.8	4.4	3.0	0.0	3.8	3.0	0.3	0.3	0.0	4.9	8.5	9.7	3.5	2.8	0.0	9.8	0.7	0.7	0.0	0.4	0.1	1.3	0.3	1.4	7.8	2.9	0.9	2.6	4.6	3.1	7.9	3.3	6.8	12.1	3.4	3.8	0.7	0.8	6.5	3.2	3.9	1.0	2.5	4.4	6.8	4.9	3.7	4.3	4.5	3.0	5.7	2.6	11.7	0.2	3.3	8.4	2.8	0.0	0.3	0.0	0.5	0.1	0.9	1.2	0.4	0.3	0.3	1.2	0.4	0.1	0.3	0.2	0.2	0.3	0.2	0.1	0.9	2.7	1.2	1.6	0.5	3.5	2.1	0.9	2.6	1.0	2.2	5.4	1.1	0.0	0.0	25.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.8	0.2	0.4	1.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	15.0	0.2	0.0	0.0	13.6	7.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471752	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pancreas: 30.7;testis: 100.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 796.2;Late spermatids: 175.5;Spermatocytes: 552.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.4;U-266/70: 5.3;U-266/84: 8.8;U-87 MG: 4.0"					"Low region specificity"	"Detected in many"			HPA078808			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA078808: "	"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.6	1.0	1.8	1.0	3.4	0.0	3.6	2.6	2.1	2.6	1.6	1.8	0.9	1.4	5.1	1.8	2.9	1.2	1.1	1.2	1.2	2.5	0.8	0.9	1.2	2.0	1.6	4.5	30.7	2.0	2.9	0.8	2.4	2.2	1.9	7.9	6.2	2.0	2.1	1.1	0.8	1.4	0.8	0.6	2.5	100.0	1.7	0.4	7.7	0.9	0.7	1.3	0.5	0.9	0.4	0.0	0.2	0.1	2.2	2.4	0.1	0.0	0.0	0.0	0.2	0.0	1.7	2.7	0.3	0.0	2.3	0.3	1.7	0.0	0.2	1.0	1.7	0.0	0.2	0.0	1.1	0.0	0.0	0.6	0.0	1.0	0.0	1.4	0.8	0.7	0.2	0.2	2.9	0.7	0.0	0.0	0.2	0.3	1.3	0.1	0.0	0.4	0.6	0.0	8.4	1.5	0.0	0.9	0.7	0.4	3.8	0.0	0.5	0.3	0.7	0.1	0.1	5.3	8.8	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	2.6	2.1	1.2	1.2	2.0	1.6	2.4	0.8	1.7	0.9	0.4	0.0	0.0	0.7	0.9	0.3	0.4	0.3	1.8	0.5	2.9	4.7	4.2	0.0	0.0	1.8	0.0	0.1	0.0	0.3	1.9	2.6	796.2	1.8	0.2	1.2	0.0	0.0	3.5	3.5	0.1	2.1	0.5	1.0	0.0	0.2	2.2	0.5	0.1	0.0	1.3	1.1	4.1	0.0	0.3	175.5	7.2	0.9	3.6	1.9	0.1	3.1	1.0	0.5	1.8	2.2	0.3	6.0	9.3	0.4	0.0	2.3	4.4	5.3	0.0	1.7	2.5	552.8	6.1	1.5	0.4	0.0	0.3	0.7	1.1	0.1
CCDC81	"FLJ16339, FLJ23514"	ENSG00000149201	"Coiled-coil domain containing 81"	Q6ZN84	11	86374736-86423109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 10.2;fallopian tube: 27.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.5;Endometrial ciliated cells: 72.7;Extravillous trophoblasts: 35.8;Respiratory ciliated cells: 38.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 3.4;BJ hTERT+: 1.8;HBF TERT88: 1.9;SuSa: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.02e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.00e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.14e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	0.7	0.3	1.5	0.2	1.4	0.2	0.4	1.8	1.4	1.9	10.2	0.5	0.0	1.6	0.5	0.2	27.4	0.4	0.4	1.8	2.3	0.4	0.3	1.4	0.4	4.0	5.5	0.8	0.2	0.1	1.8	0.6	3.9	0.7	0.2	1.0	0.2	0.7	0.8	0.4	0.3	1.1	3.5	0.4	0.4	5.8	2.0	0.8	0.7	0.1	0.3	0.6	0.5	2.4	0.0	0.1	1.1	0.0	0.3	0.1	0.4	3.4	1.8	0.5	0.4	0.4	0.3	0.2	1.3	0.6	0.1	0.2	0.6	0.1	1.9	0.2	0.2	0.3	0.1	0.3	0.1	0.2	0.3	0.0	0.6	0.9	0.3	0.6	0.6	0.2	0.2	0.0	0.4	0.5	0.4	1.0	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	0.2	0.0	2.1	0.2	0.4	0.1	0.8	0.4	0.8	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	1.8	1.4	1.8	2.3	4.0	5.5	3.9	3.5	2.0	2.4	0.1	3.2	0.5	4.6	0.0	0.3	0.2	1.0	0.0	1.8	0.7	0.6	1.1	0.0	5.2	0.0	0.0	4.0	0.2	0.1	0.0	0.1	37.5	72.7	1.0	0.4	0.0	0.0	2.3	0.0	35.8	1.0	0.0	1.3	0.0	0.3	1.8	0.0	2.1	0.0	3.8	0.0	2.0	0.6	0.7	5.1	1.5	0.5	0.0	1.0	0.6	0.4	0.0	2.5	3.5	0.0	0.1	0.7	0.0	0.6	0.1	0.1	38.4	1.0	13.1	0.7	0.9	5.8	0.3	0.0	0.6	2.7	0.2	1.0	0.1	0.2
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504596-205532793	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 179.6;heart muscle: 116.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 462.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 32.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.5;HeLa: 35.3;hTERT-RPE1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	6.1	9.0	68.6	4.1	131.1	1.1	5.1	141.2	82.6	10.9	40.0	13.1	28.8	8.6	3.4	5.7	8.6	10.4	116.3	57.8	90.8	26.5	10.6	11.0	2.8	179.2	148.1	12.6	16.9	7.8	11.5	16.1	147.7	9.2	9.2	13.3	29.2	23.6	6.1	3.3	24.9	7.0	115.2	9.5	35.8	1.6	122.1	3.6	9.5	5.3	3.7	5.7	7.5	179.6	22.2	1.4	0.2	1.3	0.0	0.0	22.6	0.4	4.1	1.0	5.5	9.4	17.8	12.4	3.2	0.2	1.9	21.2	4.9	38.5	0.9	3.4	3.8	3.0	35.3	10.5	4.0	0.1	0.2	2.5	1.9	0.1	0.8	32.2	0.0	18.4	0.1	15.2	0.3	17.7	1.2	0.6	18.4	6.1	0.9	1.6	0.1	16.6	3.6	13.5	7.9	2.8	6.4	3.2	14.2	24.5	15.3	6.2	0.0	0.0	8.1	0.1	0.1	4.1	2.1	2.5	0.2	9.4	3.7	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	68.6	131.1	141.2	82.6	57.8	90.8	179.2	148.1	147.7	115.2	122.1	179.6	4.6	0.0	0.5	12.4	1.0	3.4	6.9	17.4	11.4	7.0	4.6	5.6	29.6	5.7	6.8	73.5	0.0	5.7	0.2	12.1	7.9	18.5	2.4	2.1	0.7	2.9	6.0	1.3	12.0	6.7	2.3	3.8	15.8	4.6	0.0	13.3	2.5	3.7	5.3	0.0	4.5	12.9	2.0	3.8	4.5	4.0	0.9	3.8	3.6	12.2	4.4	28.2	1.0	4.5	462.9	6.5	111.2	1.5	0.9	10.8	35.6	18.7	3.3	1.2	6.6	5.8	12.8	6.6	17.0	5.3	1.3	1.9	1.4	22.7	13.7	9.2
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550717	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 87.2;Astrocytes: 79.7;Hepatic stellate cells: 58.5;Hepatocytes: 65.5;Microglial cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 52.7;SuSa: 37.6;TIME: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"		No	No				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"	"Nuclear bodies"	"CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102"	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	5.0	11.5	23.6	1.5	23.0	0.0	19.8	19.8	18.5	32.0	47.2	3.2	1.2	17.8	4.4	11.0	8.9	2.8	20.1	18.6	24.2	68.3	36.0	21.0	1.1	28.9	28.2	5.8	18.6	9.6	4.1	28.8	27.7	28.7	2.3	12.3	32.3	16.2	0.7	11.5	2.5	10.8	20.0	0.4	15.5	6.6	29.9	4.6	19.8	1.9	3.2	8.9	20.2	15.7	0.0	1.3	13.1	0.0	0.0	0.0	0.2	0.2	2.9	1.1	2.4	8.4	0.1	0.0	11.4	1.7	1.9	0.0	6.2	0.1	1.8	0.1	1.0	0.1	0.1	5.7	0.2	0.1	0.0	0.4	0.4	1.3	0.0	4.4	52.7	0.5	0.0	0.0	2.1	2.4	0.0	0.2	6.5	3.7	0.6	0.1	6.6	0.3	4.4	0.0	0.3	0.7	0.0	5.1	0.0	37.6	0.5	0.6	32.5	0.0	3.3	0.1	1.9	0.0	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	23.0	19.8	18.5	18.6	24.2	28.9	28.2	27.7	20.0	29.9	15.7	3.9	51.3	87.2	79.7	0.2	4.6	13.4	5.1	4.6	0.4	27.4	27.1	21.0	10.0	11.7	22.0	0.0	1.0	1.6	0.9	41.1	9.9	3.0	11.0	9.4	21.8	13.1	2.7	0.7	13.2	1.0	17.1	11.2	11.8	1.3	3.5	58.5	65.5	0.3	0.0	1.9	3.7	18.3	1.6	4.9	18.1	19.9	0.9	7.2	156.4	0.6	43.7	0.0	11.1	1.5	4.3	1.2	27.8	0.0	18.6	0.2	39.4	2.2	1.4	0.0	6.6	2.3	0.6	0.6	0.8	2.4	1.4	1.2	0.6	2.2	7.0
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769709-45782552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Sertoli cells: 59.2;Smooth muscle cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 85.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 8.7"	"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	24.2	68.3	22.1	17.5	24.0	3.0	19.1	22.2	33.1	42.8	25.6	121.5	15.8	92.7	5.3	33.4	61.2	13.9	171.3	21.8	21.6	20.3	8.8	29.8	5.2	24.0	23.8	31.1	34.3	2.9	37.9	8.8	22.3	56.4	4.8	4.1	18.6	37.6	173.6	12.3	34.6	59.9	21.9	17.8	51.7	13.2	23.8	4.2	21.7	143.2	1.3	69.1	34.3	21.3	11.7	16.7	13.5	10.7	13.4	12.9	10.5	26.1	22.2	10.5	8.8	2.2	6.6	2.9	2.8	32.9	9.2	15.1	3.0	1.5	2.2	12.4	16.6	0.8	22.6	1.4	12.6	0.1	5.4	22.8	8.0	6.4	1.7	24.2	3.6	2.1	8.6	8.0	15.4	13.7	1.6	3.8	8.8	4.8	3.3	5.0	85.1	6.4	4.7	11.5	10.2	13.5	13.6	27.6	9.3	4.8	28.6	5.5	8.4	9.2	10.4	8.3	15.0	16.8	11.5	2.9	9.5	1.3	13.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	24.0	22.2	33.1	21.8	21.6	24.0	23.8	22.3	21.9	23.8	21.3	10.5	0.0	2.2	44.1	3.7	8.0	8.1	3.8	5.7	5.7	9.6	9.9	3.7	4.3	3.2	3.7	8.4	2.7	4.2	4.7	1.9	2.7	1.5	8.7	8.6	7.9	10.1	0.4	16.4	17.3	2.0	8.4	8.2	6.3	0.0	9.7	9.3	1.5	0.8	5.0	12.4	8.2	8.2	1.6	9.8	1.8	7.2	0.8	7.2	10.3	0.4	2.6	5.2	26.7	10.0	5.8	4.5	23.3	3.1	4.0	3.8	31.7	7.1	7.4	59.2	27.6	34.9	7.2	6.4	10.1	6.8	1.6	4.5	5.4	5.1	4.6
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 488.1;hTERT-HME1: 371.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	60.9	86.2	206.5	16.2	275.8	3.3	117.3	240.6	221.9	158.8	143.3	173.2	25.4	167.1	38.2	66.1	103.9	32.6	166.0	194.6	230.7	52.2	80.8	108.0	11.3	258.1	250.4	78.2	39.8	36.7	78.8	28.7	263.4	84.5	32.4	87.4	100.3	48.7	143.1	166.2	64.2	106.0	209.1	36.7	68.9	28.4	243.3	31.4	29.8	104.1	15.2	90.4	113.2	325.4	62.4	26.6	41.2	20.8	79.5	103.5	24.6	82.2	89.7	37.8	42.1	17.1	15.5	10.4	32.2	220.7	35.6	46.7	34.4	161.2	73.0	52.3	45.2	17.8	49.5	31.4	65.9	15.0	0.4	58.3	488.1	92.5	371.6	69.1	73.3	9.5	12.6	38.2	113.9	20.2	5.1	6.8	27.7	35.6	21.9	0.1	28.8	16.5	118.8	83.0	47.2	37.8	32.7	11.7	64.1	67.7	18.6	27.2	176.5	77.3	55.9	37.0	68.9	39.6	28.6	5.0	55.8	8.8	40.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	0.3	1.3	0.0	0.1	206.5	275.8	240.6	221.9	194.6	230.7	258.1	250.4	263.4	209.1	243.3	325.4	193.2	336.5	11.8	1048.7	5.6	2368.6	1651.4	250.1	3008.4	673.1	81.0	301.5	862.8	77.2	161.7	55.2	1401.1	61.5	7.8	357.8	7.9	204.3	53.6	133.8	218.4	122.7	44.9	12.4	550.4	66.3	11.6	212.5	71.9	166.8	17.1	478.7	60.7	80.3	21.8	307.9	591.7	100.3	118.0	74.2	124.6	15.5	133.3	56.6	215.3	215.5	46.6	200.8	2.1	630.3	1410.3	194.1	283.0	152.4	27.2	229.8	124.2	10.3	52.0	122.6	65.7	381.8	196.6	20.0	13.7	298.2	857.2	26.5	19.7	30.5	48.1	142.8
EDIL3	DEL1	ENSG00000164176	"EGF like repeats and discoidin domains 3"	O43854	5	83940554-84384880	"Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 256.8"	"Group enriched"	"Detected in many"	6	"Oligodendrocyte precursor cells: 561.4;Oligodendrocytes: 2119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 547.0;LHCN-M2: 169.8;TIME: 203.3;U-2 OS: 163.2;U-87 MG: 112.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020415	Approved				"Secreted to blood"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA020415: AB_2670434"	"unprognostic (9.93e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-3)"	13.9	21.7	55.3	13.6	126.6	0.2	6.2	93.9	105.1	17.5	7.6	37.0	17.0	26.8	44.9	17.0	10.9	34.0	20.6	68.1	90.1	10.7	0.7	20.9	0.8	118.1	89.3	10.1	3.4	4.2	2.9	4.6	121.0	13.5	38.4	40.2	3.9	22.1	0.8	9.7	26.2	25.8	99.1	3.2	19.7	2.3	82.3	0.3	4.0	0.7	3.6	15.7	9.5	256.8	0.1	1.5	1.4	0.0	3.7	0.2	0.1	4.8	0.0	12.6	16.9	0.0	21.2	0.0	0.1	0.1	8.8	19.6	0.0	0.8	9.3	0.1	9.2	0.0	54.5	0.0	99.9	1.0	0.2	25.6	2.6	61.0	8.5	547.0	21.7	0.0	0.0	0.3	169.8	0.1	0.1	0.3	8.7	0.0	39.4	0.1	41.4	0.1	28.2	0.0	4.5	0.5	0.0	0.3	0.1	26.1	0.2	0.2	203.3	60.8	163.2	2.1	56.6	1.6	0.0	0.1	112.6	0.1	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	126.6	93.9	105.1	68.1	90.1	118.1	89.3	121.0	99.1	82.3	256.8	3.1	9.6	6.0	14.0	0.1	12.1	1.7	13.7	14.8	179.2	0.3	11.7	13.3	0.0	4.5	3.7	2.1	0.3	0.1	5.9	0.0	0.1	32.8	0.4	7.2	10.4	22.9	0.0	219.9	0.0	0.0	34.8	0.0	0.3	5.7	1.3	1.4	0.1	0.3	5.0	216.5	9.2	2.0	0.0	3.3	19.8	2.5	0.3	3.6	32.8	0.0	5.4	0.0	561.4	2119.7	0.4	8.1	3.8	0.0	0.9	0.0	0.9	1.2	11.6	6.6	0.2	40.2	1.9	1.5	9.3	16.1	0.4	0.6	16.2	8.4	0.7
EDNRA	"ET-A, ETA-R, hET-AR"	ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 113.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 117.1;Leydig cells: 43.8;Peritubular cells: 68.1;Sertoli cells: 52.6;Smooth muscle cells: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;ASC TERT1: 18.2;HHSteC: 9.3;LHCN-M2: 22.7;SH-SY5Y: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	14.0	5.5	2.1	3.3	2.8	0.0	8.3	2.7	4.2	57.0	2.1	3.2	3.4	44.7	23.3	4.4	18.4	12.7	26.0	2.2	2.2	4.2	3.1	22.7	3.8	2.9	3.1	37.5	1.1	3.4	2.8	12.1	2.9	30.7	3.4	0.3	6.4	113.9	4.0	4.6	2.9	45.1	2.5	8.4	5.4	6.2	2.9	4.9	6.8	5.5	2.6	11.8	24.0	3.0	0.0	1.2	5.2	0.0	9.4	18.2	0.0	2.9	3.8	0.4	0.1	0.2	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.7	0.2	0.0	1.9	0.0	2.8	0.0	9.3	0.0	0.0	6.9	0.6	0.5	0.0	3.4	0.0	0.0	0.0	1.4	22.7	0.3	0.0	0.1	1.5	0.0	1.1	0.0	0.9	0.1	1.3	1.0	0.0	16.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.6	0.7	0.0	0.0	1.3	0.4	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.8	2.7	4.2	2.2	2.2	2.9	3.1	2.9	2.5	2.9	3.0	7.7	3.2	5.3	1.0	0.0	3.1	0.8	1.7	27.3	0.1	0.8	5.2	24.9	0.0	4.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	2.9	3.4	117.1	8.0	0.0	0.0	5.3	0.0	0.1	15.9	0.0	2.7	0.0	14.3	0.0	0.0	0.6	0.0	22.5	0.0	0.0	0.0	3.9	3.5	43.8	0.8	3.6	9.4	0.0	0.1	0.0	2.0	1.0	0.2	0.0	68.1	0.0	1.4	0.0	0.5	0.0	0.5	52.6	0.6	108.6	0.7	0.7	7.1	2.7	0.1	0.9	0.3	0.0	0.4
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0"	"Group enriched"	"Detected in many"	7	"HDLM-2: 147.5;Karpas-707: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	11.8	8.3	5.9	24.7	5.5	27.5	10.8	5.0	6.3	17.5	5.0	14.3	9.3	28.0	19.3	19.2	14.0	27.7	8.5	5.3	6.3	7.6	5.4	16.1	20.2	7.1	6.5	5.5	2.8	3.4	3.9	11.4	7.7	11.2	12.8	6.8	6.0	18.1	4.0	6.3	11.7	49.7	6.2	21.5	7.3	4.5	7.5	6.8	20.0	8.7	25.6	30.6	11.0	6.3	1.4	2.7	5.4	7.1	0.1	0.1	5.0	4.5	1.2	0.0	0.0	4.0	1.6	8.2	3.1	0.0	5.3	2.2	0.0	0.0	0.0	147.5	5.2	7.2	4.0	4.3	0.0	12.5	4.1	0.1	0.0	0.6	0.0	2.4	18.2	2.0	5.3	135.4	0.1	4.4	4.7	5.8	5.9	3.6	2.8	15.3	2.4	4.4	1.7	2.2	5.1	6.2	3.6	3.7	3.9	3.6	5.5	5.9	3.9	3.9	2.8	3.8	5.3	21.6	7.2	0.6	4.3	13.9	2.7	0.7	41.0	102.2	0.6	27.2	1.1	13.7	1.6	1.1	31.9	11.4	0.6	0.6	49.4	1.5	6.7	2.1	13.1	15.5	5.9	5.5	5.0	6.3	5.3	6.3	7.1	6.5	7.7	6.2	7.5	6.3	19.6	0.0	1.1	74.1	40.9	8.9	0.3	0.0	0.6	1.4	0.8	1.5	10.1	0.0	0.7	1.8	2.1	0.6	3.7	0.3	1.9	0.0	10.3	0.6	3.6	60.6	0.0	4.4	2.8	2.0	1.9	15.7	6.1	0.6	3.8	0.3	31.4	0.8	26.6	0.0	5.2	0.1	0.0	110.4	161.3	7.3	0.6	62.1	16.0	217.4	112.2	0.4	0.0	20.6	5.0	0.2	1.2	3.0	80.1	0.5	0.1	0.3	0.8	0.8	6.6	1.0	22.7	10.1	4.4	0.8	11.2	15.7	26.9	15.1	1.0	0.5
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729940-82733864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Enhanced		Approved	"Nuclear membrane,Mitochondria"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nuclear membrane"	"HPA066861: AB_2685738"	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	0.5	0.6	18.0	0.2	20.3	0.1	0.4	19.8	14.3	1.3	5.9	1.4	0.2	0.7	0.1	0.3	1.0	0.0	1.7	14.5	14.7	0.7	0.0	0.0	0.0	26.9	20.8	0.8	0.5	0.1	1.2	0.0	16.3	0.6	0.0	0.6	0.8	0.5	0.2	0.3	0.4	0.1	23.9	0.0	0.4	0.2	19.9	0.0	0.8	0.1	0.2	1.1	0.7	23.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	20.3	19.8	14.3	14.5	14.7	26.9	20.8	16.3	23.9	19.9	23.6	0.7	0.0	0.0	56.2	0.0	0.3	0.2	0.1	0.0	0.8	1.0	3.6	2.9	0.0	0.1	5.5	0.0	0.0	0.0	0.0	3.9	0.1	0.0	24.1	1.8	1.3	0.0	0.0	0.4	0.0	0.0	1.2	0.0	2.4	0.0	0.6	0.0	0.0	0.1	0.0	0.6	1.5	0.0	0.0	0.3	0.4	0.6	0.2	1.8	1.9	0.0	18.4	0.0	22.1	19.0	0.0	0.0	0.4	0.0	0.2	0.1	0.4	0.1	1.1	0.0	1.6	7.0	0.1	1.6	0.3	0.0	0.0	0.1	2.2	0.2	0.1
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 210.1;Early spermatids: 376.7;Sertoli cells: 256.4;Skeletal myocytes: 184.2;Smooth muscle cells: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.1;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 84.2;HDLM-2: 79.9;TIME: 145.8"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 18.0"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	77.1	21.7	4.9	52.4	6.3	0.8	32.6	4.8	6.6	63.8	4.0	57.7	28.4	117.6	23.8	56.0	31.2	90.9	54.8	6.2	4.4	24.0	28.1	30.7	30.1	9.6	4.2	76.4	35.5	17.5	3.9	43.9	9.7	67.9	29.8	4.7	9.3	54.3	140.4	16.8	41.2	151.7	3.7	42.9	46.7	22.0	3.6	11.9	20.1	161.5	22.3	101.5	21.9	4.0	59.0	0.0	22.3	0.1	35.8	30.2	2.0	29.4	58.8	50.2	56.5	17.8	0.2	0.2	5.0	84.2	13.2	7.1	0.0	14.4	59.0	79.9	0.6	4.8	0.2	23.3	17.8	1.4	0.0	24.2	5.1	5.6	0.0	32.0	22.8	0.0	3.8	0.5	7.7	0.1	5.2	1.2	1.3	3.1	0.0	0.1	26.1	0.7	33.5	1.0	2.0	3.7	0.4	0.4	0.1	11.7	0.0	10.5	145.8	8.8	0.2	1.9	15.5	4.2	0.2	0.3	6.5	0.4	0.0	0.2	0.4	0.0	0.1	1.0	0.0	0.6	0.1	0.1	2.1	0.6	0.0	0.1	0.2	0.4	2.9	0.4	0.1	0.3	4.9	6.3	4.8	6.6	6.2	4.4	9.6	4.2	9.7	3.7	3.6	4.0	92.9	16.0	23.1	9.4	4.1	27.8	56.7	7.9	2.2	11.8	12.3	6.5	145.7	35.8	2.3	5.5	8.4	1.1	1.8	2.1	1.9	210.1	376.7	2.3	60.5	77.2	3.0	0.0	42.0	109.3	0.7	145.2	21.9	2.4	34.8	16.3	41.0	0.7	3.2	106.0	25.8	5.7	6.1	36.3	98.9	180.2	83.0	86.1	17.8	25.3	17.7	0.9	0.0	22.1	21.6	43.7	0.2	104.2	3.0	5.1	5.4	2.6	1.9	6.0	256.4	184.2	351.9	40.1	2.5	1.5	22.7	3.1	8.8	41.8	3.2	3.5
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.7;skin 1: 9.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	0.7	0.1	0.7	0.1	0.6	0.0	0.8	1.2	0.6	6.5	0.2	0.3	0.1	2.8	0.9	16.7	1.4	1.6	0.2	0.6	0.6	0.6	0.0	0.8	0.4	1.2	1.0	2.9	0.1	0.0	0.9	2.3	1.1	2.9	0.2	0.4	4.2	1.5	1.0	9.4	0.4	0.4	0.7	0.0	0.4	0.1	2.7	0.3	1.0	0.8	0.7	2.6	6.8	1.1	0.0	0.0	5.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	1.2	0.6	0.6	0.6	1.2	1.0	1.1	0.7	2.7	1.1	0.4	0.0	0.5	0.0	0.0	8.4	4.7	0.1	12.5	0.1	0.6	0.8	0.6	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	2.1	2.1	0.0	0.0	0.0	0.2	0.6	8.4	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	13.1	9.3	0.0	0.4	25.5	8.5	0.8	0.1	0.0	0.0	1.8
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 5.3;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	3.1	6.0	5.7	0.3	5.7	0.0	4.4	11.6	6.0	6.0	2.0	2.9	1.8	7.4	5.2	4.4	5.4	3.7	11.3	6.9	5.2	2.1	1.8	2.4	1.3	4.7	4.5	4.5	2.1	6.6	2.0	1.4	5.8	6.2	1.9	1.3	5.0	4.0	1.5	2.8	1.8	6.7	4.6	1.8	1.8	2.9	4.2	0.6	5.7	1.8	1.3	4.6	3.3	11.2	0.5	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	1.0	1.2	0.3	0.0	1.0	0.1	0.4	0.6	1.8	0.0	0.1	0.0	0.8	0.0	1.9	1.2	0.4	0.4	0.1	0.1	1.5	0.0	0.0	1.5	0.7	1.9	0.8	0.7	0.1	0.5	0.0	0.3	0.4	5.3	1.6	0.1	1.1	3.4	1.9	2.5	1.2	3.9	0.8	2.7	0.4	0.6	0.9	0.0	0.0	0.2	1.0	0.0	0.4	2.3	2.4	1.0	0.4	0.5	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	5.7	5.7	11.6	6.0	6.9	5.2	4.7	4.5	5.8	4.6	4.2	11.2	1.3	0.0	0.0	77.1	0.5	2.7	1.7	0.4	2.8	8.0	3.1	4.3	6.8	4.3	2.0	3.7	0.0	0.6	0.2	0.9	1.9	0.3	2.2	1.0	21.1	1.5	1.2	0.4	178.4	0.6	0.1	4.8	5.6	1.2	0.0	2.4	1.8	2.5	0.8	1.7	184.7	0.8	0.0	1.3	1.9	1.0	7.5	1.3	1.8	48.7	0.0	4.0	0.0	45.2	165.3	0.4	1.6	3.4	0.5	3.3	0.6	1.8	0.1	1.0	0.0	7.1	4.0	3.5	3.9	2.7	2.0	0.3	0.7	1.0	0.8	1.2
GFRA3	GFRa-3	ENSG00000146013	"GDNF family receptor alpha 3"	O60609	5	138252380-138274621	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.7;Enteroendocrine cells: 53.1;granulocytes: 26.7;Late spermatids: 20.9;Spermatogonia: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.9"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 32.0"	"Not detected"	"Not detected"							HPA020731	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		150000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Plasma membrane"	Cytosol	"HPA020731: AB_1849635"	"unprognostic (1.22e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	1.8	1.6	0.0	2.1	0.2	0.0	1.6	2.5	0.3	7.4	0.0	13.0	2.7	0.5	2.5	2.3	1.2	1.9	5.7	0.1	0.2	0.5	0.5	2.0	0.1	0.1	0.1	1.3	3.7	0.0	2.0	0.0	0.2	4.1	3.8	0.0	3.2	5.9	0.2	3.1	3.3	2.0	0.1	0.0	6.3	4.2	0.1	0.5	0.8	0.4	0.1	5.1	7.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.1	0.0	0.0	2.0	1.2	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	32.0	0.5	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	8.7	0.0	0.0	0.0	53.1	0.0	0.2	0.2	0.2	0.5	0.0	0.0	26.7	0.3	0.0	0.0	0.1	0.0	0.1	0.2	6.1	0.0	0.2	20.9	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.8	8.4	0.1	0.0	0.3	0.0	0.1	0.0	0.1
GIPC3	"C19orf64, DFNB15, DFNB72, DFNB95"	ENSG00000179855	"GIPC PDZ domain containing family member 3"	Q8TF64	19	3585478-3593541	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 16.7"	"Group enriched"	"Detected in some"	4	"Adipocytes: 10.4;Endothelial cells: 6.2;Hepatic stellate cells: 12.8;Rod photoreceptor cells: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 19.0;HMC-1: 11.8;THP-1: 23.1;WM-115: 44.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067765			Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA067765: "	"unprognostic (1.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	4.6	2.2	1.4	1.0	1.0	0.3	2.8	1.0	1.1	3.0	0.8	1.9	1.2	2.8	2.9	5.2	2.1	2.1	3.9	1.2	1.2	3.6	1.4	3.8	2.4	1.6	1.2	0.7	0.7	2.7	1.0	1.1	1.6	3.5	1.4	16.7	0.7	2.3	1.7	1.1	4.4	8.3	1.4	3.9	2.0	0.3	1.6	3.1	3.0	1.9	1.6	1.1	1.8	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.9	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4	0.0	1.5	0.0	0.2	6.9	19.0	0.0	0.7	0.0	11.8	0.2	0.0	1.1	0.0	0.0	2.1	0.2	3.2	0.0	0.3	0.0	0.0	1.1	0.7	0.0	1.2	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.5	0.0	4.7	1.1	0.0	23.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.0	1.1	1.2	1.2	1.6	1.2	1.6	1.4	1.6	1.1	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.1	0.3	2.4	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	12.8	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.8	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.2	1.1	0.0	0.4	0.1	0.3	0.1	0.3	0.1	0.0	0.1
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238587-16295549	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 358.6;tongue: 205.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Endometrial ciliated cells: 118.2;Erythroid cells: 367.1;Melanocytes: 92.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 14.9;monocytes: 5.0;NK-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"HEL: 193.1;HMC-1: 314.7;SK-MEL-30: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		950000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	10.0	23.3	28.5	2.8	31.9	29.7	6.5	32.4	21.6	6.6	35.7	15.5	2.7	13.3	16.5	5.3	56.9	3.7	101.7	19.6	38.2	25.5	5.9	9.1	2.5	36.8	45.6	38.0	18.3	14.2	24.9	7.8	35.0	63.1	3.4	2.2	21.5	9.0	358.6	12.4	6.0	9.9	39.7	12.5	36.5	52.3	41.3	6.5	4.4	205.0	1.6	5.2	3.7	33.2	0.0	0.0	0.3	0.0	2.7	2.1	0.1	3.9	15.7	27.2	55.2	1.6	0.4	0.0	8.8	6.0	19.1	0.1	6.7	0.8	4.5	0.0	5.0	193.1	0.1	0.0	11.8	0.8	314.7	3.7	2.8	8.5	0.0	22.2	49.5	0.7	43.9	0.3	4.8	3.8	0.2	4.1	2.0	0.2	7.5	0.0	41.9	0.0	36.1	5.4	9.4	1.2	1.9	3.2	74.4	12.1	3.0	1.4	12.5	0.4	0.2	1.3	7.5	2.3	0.0	0.0	0.9	20.3	21.8	14.9	3.3	0.4	0.7	5.0	1.2	0.2	0.1	0.5	1.5	1.5	0.0	0.2	3.3	9.6	1.7	1.5	0.0	16.0	28.5	31.9	32.4	21.6	19.6	38.2	36.8	45.6	35.0	39.7	41.3	33.2	4.6	0.0	0.0	8.8	1.3	5.1	30.2	0.7	0.6	0.7	5.3	3.8	52.8	35.8	2.7	20.2	0.0	25.3	0.6	1.4	86.1	12.4	16.0	118.2	8.7	6.8	7.8	367.1	3.8	4.9	2.8	10.2	9.2	78.9	55.3	38.9	17.9	5.0	8.9	0.0	11.5	3.2	4.1	6.4	2.1	16.3	34.5	47.4	92.5	2.8	9.2	9.8	2.1	3.0	1.7	3.0	1.2	80.9	1.4	69.9	2.2	15.5	6.4	0.8	0.0	12.6	7.4	6.5	17.2	1.3	1.8	6.8	3.5	19.4	3.8	8.3
GNAO1	G-ALPHA-o	ENSG00000087258	"G protein subunit alpha o1"	P09471	16	56191390-56357444	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 171.2;retina: 52.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.8;Bipolar cells: 189.2;Excitatory neurons: 138.7;Inhibitory neurons: 132.2;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 368.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.7;BJ hTERT+ SV40 Large T+: 20.0;SCLC-21H: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008387, HPA040878"	Enhanced					NA	NA		510000		"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB008387: AB_591430, HPA040878: AB_2677184"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.00e-1)"	"unprognostic (9.70e-5)"	3.0	7.9	100.8	3.4	171.2	0.1	1.1	55.1	121.9	2.1	0.0	34.0	3.1	7.7	3.0	2.9	2.9	2.5	34.1	101.9	87.6	1.1	10.2	0.9	1.1	74.6	89.6	1.7	3.9	1.5	28.5	0.5	77.9	5.1	5.1	52.4	2.3	16.5	2.0	1.4	7.3	10.2	44.6	1.3	11.0	13.8	107.3	1.1	1.9	0.6	1.1	7.9	2.5	110.3	7.3	0.0	0.6	0.1	0.0	0.1	0.9	7.6	30.7	20.0	9.5	0.4	0.0	0.0	0.2	0.0	7.3	0.6	4.9	0.0	13.7	0.2	0.9	0.0	2.0	0.0	0.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0	0.0	6.1	0.0	0.2	0.0	0.8	0.0	0.1	11.1	0.3	0.1	0.1	7.1	0.1	0.0	0.0	61.2	12.2	12.5	0.2	0.7	3.1	0.2	0.0	0.0	0.2	6.8	0.0	3.6	0.8	0.0	0.1	0.3	0.5	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	100.8	171.2	55.1	121.9	101.9	87.6	74.6	89.6	77.9	44.6	107.3	110.3	0.6	0.0	0.5	135.8	0.8	0.8	0.3	0.2	0.0	189.2	1.4	0.6	43.3	1.5	0.1	0.0	6.2	0.4	4.9	0.1	0.0	0.0	26.8	0.7	4.4	1.5	23.3	0.8	138.7	0.0	0.2	6.8	1.5	1.2	0.0	0.2	0.7	10.4	0.1	79.1	132.2	1.0	0.0	0.8	2.1	53.6	34.8	1.7	3.6	13.1	0.0	20.5	1.0	87.9	368.3	0.3	0.0	44.4	2.1	0.4	0.1	0.3	0.1	13.1	0.0	8.2	5.6	15.4	8.8	0.3	0.4	0.1	7.2	0.1	0.3	0.2
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182928	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 839.8;Inhibitory neurons: 904.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 31.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.4;RPMI-8226: 1.8;U-138 MG: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.3	0.3	4.7	0.0	8.4	0.0	0.1	0.0	31.7	0.3	0.0	0.2	0.3	0.3	2.5	1.1	2.1	0.1	3.0	20.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	2.2	0.2	0.3	0.0	0.5	0.2	0.4	0.0	0.0	0.4	2.1	0.1	0.6	0.2	0.2	0.2	0.1	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.3	1.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.4	0.0	31.7	20.0	0.0	0.0	0.0	0.0	0.0	0.1	10.3	0.2	0.0	0.0	16.0	0.0	1.9	2.2	0.5	3.4	10.3	0.3	0.0	18.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2.1	17.2	0.3	0.1	0.5	0.0	0.0	839.8	0.2	0.0	2.7	0.0	0.7	0.0	3.3	0.0	0.3	0.1	1.7	904.7	0.0	0.0	0.3	0.4	15.1	0.9	0.1	0.0	15.9	0.0	15.6	0.0	27.6	65.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.9	0.0	0.0	5.4	8.2	10.0	0.2	0.4	0.0	0.0	0.0	0.1	0.3
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
HDX	"CXorf43, FLJ30678"	ENSG00000165259	"Highly divergent homeobox"	Q7Z353	X	84317874-84502479	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.1;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 45.8;Oligodendrocytes: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047189	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA047189: AB_10965463"	"unprognostic (7.26e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-5)"	"unprognostic (3.23e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.40e-6)"	"unprognostic (1.14e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.86e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.66e-2)"	1.3	1.6	0.6	0.7	0.9	0.0	1.6	2.9	1.6	1.8	0.0	1.3	0.3	1.8	1.5	1.1	1.6	1.3	1.1	0.8	1.3	1.1	1.0	1.0	0.5	1.1	0.6	2.1	0.5	1.2	1.2	0.3	1.0	1.4	1.1	1.8	1.3	1.5	0.4	0.4	0.7	1.7	0.8	1.0	0.7	1.0	0.6	0.4	1.4	0.4	0.6	1.3	1.0	1.3	0.0	1.5	7.5	0.0	4.4	3.9	0.0	2.3	3.2	5.0	4.9	0.3	0.8	0.0	0.4	1.8	6.2	0.3	0.1	0.5	4.3	0.0	0.3	0.0	1.4	0.0	3.6	0.0	0.0	2.2	0.0	3.1	2.2	3.2	5.4	0.0	0.0	0.0	4.9	0.1	0.0	0.0	4.7	0.0	2.2	0.0	5.7	0.0	2.4	1.0	0.2	3.9	0.0	0.1	0.0	2.7	0.4	0.0	6.4	2.5	1.9	0.8	2.2	0.1	0.0	0.0	1.5	0.0	0.9	0.0	2.3	0.0	0.7	3.5	0.1	1.8	0.2	0.2	3.2	0.5	0.6	0.4	0.0	0.9	3.5	0.3	0.1	0.6	0.6	0.9	2.9	1.6	0.8	1.3	1.1	0.6	1.0	0.8	0.6	1.3	7.8	0.0	2.7	19.2	2.8	2.5	23.1	2.8	5.7	9.4	4.8	5.2	1.9	1.5	3.5	5.5	12.5	0.0	2.7	1.7	0.0	7.0	8.7	2.9	7.1	6.7	7.1	0.4	51.1	1.8	0.0	7.7	2.0	6.6	1.3	4.1	1.8	0.7	1.0	6.7	56.7	1.5	0.0	1.9	3.6	2.1	4.1	4.1	0.0	20.6	3.8	4.1	1.0	45.8	26.5	2.9	1.9	3.4	1.2	12.4	0.5	2.9	1.3	5.3	0.0	8.8	7.5	2.4	0.3	3.0	1.7	0.1	1.5	4.7	1.3	19.6
HES4	bHLHb42	ENSG00000188290	"Hes family bHLH transcription factor 4"	Q9HCC6	1	998962-1000172	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 345.1;Paneth cells: 397.4;Prostatic glandular cells: 286.6;Smooth muscle cells: 385.7;Urothelial cells: 494.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"eosinophil: 12.4"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 12.4"	"Cell line enriched"	"Detected in many"	7	"HEK 293: 198.1"					"Low region specificity"	"Detected in all"			HPA062465			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA062465: AB_2684771"	"unprognostic (6.23e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-1)"	"unprognostic (7.76e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.08e-3)"	10.5	1.9	12.9	0.7	15.3	0.5	9.1	8.1	34.3	9.2	0.9	11.0	1.2	10.5	0.4	7.5	10.3	0.1	22.6	6.8	17.9	13.6	3.0	10.8	0.2	22.3	15.8	3.9	5.6	0.9	8.4	1.5	17.0	11.4	0.3	0.8	7.7	2.2	4.0	8.4	3.9	1.2	6.0	4.4	5.6	2.6	24.0	1.4	6.0	0.9	0.3	10.0	8.4	4.0	14.3	1.6	1.5	0.2	0.2	0.1	17.6	8.6	1.0	5.2	5.4	2.3	4.5	0.0	20.0	0.7	2.3	25.3	2.1	0.3	0.2	0.1	198.1	0.1	2.4	2.9	1.7	0.0	1.7	0.1	2.0	0.3	0.4	0.7	0.6	2.5	4.1	0.3	0.0	7.6	11.7	0.6	0.2	3.1	19.2	0.2	1.9	4.4	2.0	0.0	1.1	4.6	5.8	14.3	29.1	0.7	10.5	0.0	1.1	1.6	0.6	0.0	4.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	12.4	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	12.9	15.3	8.1	34.3	6.8	17.9	22.3	15.8	17.0	6.0	24.0	4.0	90.1	0.0	0.0	18.6	15.3	52.1	345.1	1.7	6.8	8.9	158.9	149.4	13.3	20.0	4.0	58.8	0.0	1.5	22.3	88.3	31.3	44.1	1.0	74.7	30.0	63.4	10.7	2.7	12.9	2.9	43.9	65.5	11.2	153.3	53.5	3.1	37.5	0.8	4.8	0.0	25.9	25.4	4.1	10.0	120.5	1.5	7.5	70.8	115.6	11.2	5.2	129.7	12.3	8.5	1.7	10.7	397.4	15.4	2.3	286.6	1.5	0.8	1.1	11.3	164.3	157.8	385.7	3.2	29.6	43.0	82.7	3.4	27.4	2.0	56.9	494.9
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 82.3"	"Low region specificity"	"Detected in all"							"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA		1000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.3	11.3	12.0	1.0	10.5	3.0	3.5	21.7	30.6	3.5	13.5	2.6	2.3	1.0	1.2	13.7	7.0	3.7	6.4	10.6	32.7	13.3	7.4	1.5	0.3	15.2	17.7	3.8	4.0	11.1	8.0	2.9	21.5	4.1	3.5	26.9	5.7	4.9	1.5	8.4	1.2	3.0	12.9	0.9	2.1	108.7	17.7	4.0	3.9	3.6	4.7	2.8	7.7	15.9	20.6	26.5	14.0	22.1	9.5	9.5	16.2	9.1	3.7	8.6	9.5	19.7	9.2	0.1	16.4	2.6	7.0	4.7	82.3	32.9	11.7	38.7	24.7	11.0	33.5	23.7	3.5	42.3	17.9	8.7	29.7	5.7	20.3	8.9	11.3	9.4	19.8	12.2	10.9	14.9	13.6	3.7	3.3	21.5	21.6	0.1	1.5	2.0	29.1	9.2	25.7	9.4	16.4	28.2	1.5	8.3	21.7	7.1	3.2	3.0	0.1	3.7	22.1	23.6	29.3	6.4	11.7	28.3	9.4	0.6	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.0	10.5	21.7	30.6	10.6	32.7	15.2	17.7	21.5	12.9	17.7	15.9	2.7	3.2	9.3	17.6	1.1	28.4	91.9	31.3	40.9	57.7	7.7	9.4	18.1	12.8	27.6	9.2	104.3	10.0	0.8	3.4	19.6	6.8	436.6	17.8	1.6	6.8	18.4	0.0	47.1	2.9	2.1	8.1	2.6	5.2	15.8	2.5	1.8	9.7	1.2	40.4	70.4	3.5	24.4	2.5	9.7	901.8	10.2	4.7	8.8	7.5	3.0	16.6	2.1	19.6	9.3	2.8	0.3	9.8	0.4	26.2	0.3	24.6	52.0	66.8	0.0	18.7	12.5	203.1	13.5	47.5	42.5	16.7	4.2	2.8	5.3	65.2
KANK2	"ANKRD25, KIAA1518, MXRA3"	ENSG00000197256	"KN motif and ankyrin repeat domains 2"	Q63ZY3	19	11164270-11197791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 402.5;Endometrial stromal cells: 149.6;Leydig cells: 126.2;Peritubular cells: 225.7;Smooth muscle cells: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC diff: 327.8;ASC TERT1: 365.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015643	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA015643: AB_1844839"	"unprognostic (2.37e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.63e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	150.2	55.5	25.7	50.5	27.2	17.9	97.7	22.8	25.6	275.3	24.5	413.2	36.8	376.9	64.6	139.1	222.1	125.0	200.5	20.0	27.9	54.1	51.3	134.5	20.7	29.5	26.5	213.9	35.4	14.3	29.8	62.3	29.0	140.5	58.7	19.0	39.3	173.6	56.9	49.7	108.0	277.7	23.8	57.8	123.7	25.0	29.5	15.7	71.7	51.1	12.4	255.2	148.5	22.6	42.4	91.1	28.3	30.3	327.8	365.1	20.2	188.9	161.0	92.1	76.2	36.3	27.0	177.2	88.1	234.3	59.6	40.0	25.6	13.7	61.3	9.3	18.4	77.2	105.6	37.5	123.9	11.8	21.4	158.7	20.1	67.3	9.0	237.2	37.8	5.5	51.5	14.3	143.6	75.7	2.3	9.9	31.4	27.5	95.1	59.7	234.8	42.2	65.4	22.7	16.6	51.7	188.2	16.4	22.4	32.7	25.1	41.2	139.1	131.5	52.6	170.1	75.2	13.7	32.9	61.3	111.0	66.3	136.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	25.7	27.2	22.8	25.6	20.0	27.9	29.5	26.5	29.0	23.8	29.5	22.6	34.1	57.7	28.3	7.8	1.3	6.2	5.5	5.2	2.2	2.0	5.2	7.1	402.5	27.1	12.0	20.2	20.9	6.9	0.6	2.5	3.9	8.1	2.4	12.7	149.6	41.2	0.0	76.2	0.9	4.4	4.9	69.2	13.3	11.9	7.6	7.7	32.5	28.2	22.5	0.0	4.1	2.6	4.1	10.6	15.1	3.8	126.2	6.3	8.8	42.2	0.5	34.9	4.1	1.0	1.4	11.9	1.2	225.7	0.8	6.7	1.6	3.7	8.0	23.4	92.1	79.2	131.0	1.8	7.2	2.8	7.7	2.3	2.3	7.7	5.2	8.4
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;hTEC/SVTERT24-B: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	15.8	6.3	12.7	1.2	52.7	1.6	7.3	15.5	17.3	8.4	4.2	4.1	1.7	5.4	12.8	2.2	4.3	2.9	5.5	25.9	11.6	1.8	2.6	3.3	0.9	7.2	12.1	2.9	4.0	2.0	1.8	1.3	7.2	22.4	1.8	12.8	3.9	19.2	2.0	2.2	2.7	2.7	8.4	5.2	1.6	3.1	14.1	1.8	28.7	5.1	0.3	2.9	5.0	15.4	0.5	0.5	0.7	0.2	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.9	0.1	0.4	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.4	1.0	3.4	0.6	1.6	0.0	1.0	0.2	0.0	0.0	5.2	0.0	1.1	2.1	0.5	0.1	0.3	0.2	0.1	0.3	0.6	1.1	1.5	0.2	0.6	0.7	2.8	0.0	0.2	0.8	0.8	0.3	0.6	0.7	0.5	0.8	0.5	2.2	0.8	0.5	1.4	1.2	1.8	0.4	0.4	2.6	1.1	1.0	0.8	0.1	0.0	0.4	0.2	0.8	0.2	0.4	0.3	0.2	0.2	0.3	0.3	0.0	0.3	0.3	1.2	0.5	0.1	12.7	52.7	15.5	17.3	25.9	11.6	7.2	12.1	7.2	8.4	14.1	15.4	7.2	0.0	0.0	7.5	0.7	0.8	0.3	0.0	0.0	85.8	1.4	1.4	4.3	0.0	0.7	0.0	31.3	0.1	0.5	0.1	0.0	0.4	13.7	0.6	2.4	2.8	0.0	0.0	108.6	0.0	0.0	3.8	0.0	2.1	0.0	0.4	0.7	0.0	4.6	0.0	605.4	0.0	0.0	11.1	1.0	7.0	0.0	1.2	1.8	24.4	0.0	2.7	0.0	206.6	97.5	0.0	0.0	2.6	2.3	0.2	0.0	0.1	0.0	6.7	78.9	1.3	73.3	0.3	4.2	1.2	0.9	0.1	0.5	0.2	0.0	0.2
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279087-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.9;skeletal muscle: 16.5"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 283.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.4	0.4	2.9	0.1	4.8	0.4	0.3	3.1	3.7	1.3	1.8	0.5	0.3	0.7	0.2	0.5	0.7	0.2	23.9	3.2	3.2	0.8	0.2	0.4	0.0	3.7	3.7	1.2	0.2	0.0	0.1	0.1	3.4	0.4	0.1	0.3	0.2	0.4	16.5	0.2	0.3	0.4	2.7	0.2	0.3	3.9	3.8	0.0	0.2	5.5	0.0	0.4	0.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.8	3.1	3.7	3.2	3.2	3.7	3.7	3.4	2.7	3.8	6.0	1.0	0.0	0.6	0.7	0.3	1.0	0.2	0.2	0.0	0.2	1.5	0.9	4.4	0.0	0.8	1.8	0.0	0.1	0.3	0.9	0.0	0.1	40.5	3.3	0.6	0.8	0.0	0.0	0.2	0.2	0.1	0.4	0.0	10.1	5.1	0.2	0.0	0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.4	283.1	1.2	0.3	1.8	0.0	0.0	0.5	0.0	0.0	2.8	0.2	0.0	0.7	0.0	0.4	1.5	0.1	0.2	0.2	0.0	1.4	4.7	1.8	1.1	0.4	1.3	0.1	0.2	0.1	0.7	0.1
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;placenta: 15.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Early spermatids: 59.7;Inhibitory neurons: 65.9;Late spermatids: 230.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.6;fHDF/TERT166: 48.2;HBF TERT88: 25.0;LHCN-M2: 46.2;RT4: 39.9"	"Low region specificity"	"Detected in all"							HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.72e-4)"	1.4	0.3	8.0	0.6	4.6	0.0	9.3	4.5	5.5	0.9	1.2	1.5	1.7	2.1	0.1	0.5	1.6	11.1	0.6	4.7	9.8	2.0	0.3	0.2	0.2	6.8	24.0	0.6	1.9	1.4	0.3	15.7	6.7	1.4	2.5	7.0	0.2	1.3	0.1	0.6	1.4	2.9	5.6	0.6	3.9	6.8	16.1	0.3	0.2	0.1	1.3	2.6	0.4	4.2	0.2	0.0	6.8	37.6	0.0	0.1	0.5	15.0	6.6	18.9	11.7	0.2	3.0	0.0	0.8	48.2	9.1	3.8	5.3	0.1	25.0	0.0	1.7	0.1	9.6	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.0	0.4	0.3	0.0	0.0	0.0	46.2	6.7	0.0	3.6	5.4	3.2	4.3	0.0	20.1	0.0	2.3	39.9	1.5	6.7	10.1	11.2	1.2	12.2	1.5	0.8	0.0	0.4	5.7	0.5	8.2	0.0	0.0	0.0	3.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.6	4.5	5.5	4.7	9.8	6.8	24.0	6.7	5.6	16.1	4.2	0.1	0.0	0.0	40.8	0.0	0.1	0.6	1.0	1.2	2.7	11.7	6.6	0.4	10.0	2.0	0.0	0.0	0.0	0.0	0.4	3.9	2.6	59.7	1.7	0.4	0.9	0.0	0.0	0.3	0.9	0.2	1.4	10.7	2.5	0.0	0.7	0.4	0.0	0.3	0.0	65.9	2.8	0.0	0.0	0.0	230.4	3.1	0.0	0.0	1.0	0.0	4.1	0.0	13.6	1.0	4.5	0.4	0.4	0.1	2.1	1.7	0.0	0.8	3.4	0.0	0.1	0.2	1.0	5.2	0.7	0.0	0.3	0.1	0.0	2.0	1.7
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 163.3;Oligodendrocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm		NA	NA		13000000	"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	22.4	58.7	54.2	29.1	65.2	22.1	16.6	58.5	89.4	19.3	1.9	24.5	15.0	14.0	18.9	17.4	12.7	41.1	89.1	68.8	56.9	18.4	33.4	27.2	35.8	74.0	61.0	24.9	12.8	19.2	16.3	28.3	70.6	16.1	24.6	49.1	20.2	17.2	50.4	26.1	19.6	23.8	70.0	27.8	30.6	6.4	68.2	74.4	21.7	91.9	32.6	27.2	14.4	109.0	0.8	26.3	28.9	15.4	17.1	15.9	2.0	18.7	44.7	22.3	37.2	2.0	9.9	87.8	21.3	41.1	23.5	35.0	22.8	15.2	39.8	51.5	21.3	88.9	26.9	52.8	12.6	49.5	72.3	19.6	4.0	30.4	10.5	21.2	124.0	61.4	28.3	37.7	28.8	1.7	104.6	16.4	22.5	28.8	5.2	41.6	35.2	20.0	11.9	0.4	35.9	23.9	14.0	0.7	15.5	27.2	3.2	29.0	21.0	24.1	13.4	14.2	12.7	19.9	50.8	50.8	41.4	65.1	38.2	69.0	30.0	46.7	63.8	37.7	49.5	60.8	44.4	58.3	33.4	55.5	50.6	61.5	21.5	74.4	51.6	47.3	52.9	76.9	54.2	65.2	58.5	89.4	68.8	56.9	74.0	61.0	70.6	70.0	68.2	109.0	27.0	22.4	18.3	104.8	73.0	23.7	5.1	2.0	38.1	109.6	18.9	19.7	105.6	12.8	4.8	5.5	25.0	0.6	107.9	13.3	5.9	9.8	12.4	11.9	12.6	29.4	29.3	25.0	163.3	12.8	9.7	28.5	42.3	14.6	27.3	4.6	33.5	26.1	26.1	52.2	141.7	25.8	4.1	44.7	38.3	6.8	19.3	44.6	30.2	70.3	17.1	40.3	52.5	97.5	435.9	10.1	15.6	21.1	31.6	2.9	12.0	5.1	6.5	12.5	78.9	25.4	74.9	1.9	10.6	9.1	27.6	0.8	76.1	15.0	11.1	3.5
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159890988-159917447	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 9.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.0;Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 2.1;Urothelial cells: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 5.1;hippocampal formation: 9.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HMC-1: 7.5"	"Group enriched"	"Detected in many"	22	"amygdala: 38.5;basal ganglia: 26.6;cerebral cortex: 32.4;hippocampal formation: 64.6;white matter: 18.1"	"Group enriched"	"Detected in some"	4	"amygdala: 5.2;cerebral cortex: 8.0;hippocampal formation: 15.1"	HPA079325	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA079325: "	"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.0	0.0	1.7	0.0	0.7	0.3	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	5.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.2	0.6	0.0	2.0	0.0	1.4	0.0	0.0	1.2	0.1	0.3	0.8	0.0	0.6	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.8	0.0	0.0	0.1	0.0	0.3	0.7	0.0	0.3	0.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.5	0.7	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.3	0.0	2.1	0.0	1.3	1.0	0.4	0.5	0.0	0.0	0.3	0.5	0.2	0.2	1.9
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500779	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 170.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 211.3;U-266/70: 193.0;U-266/84: 214.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	33.3	32.6	15.7	24.4	22.6	79.8	27.5	21.8	24.9	43.5	0.0	43.6	16.0	48.9	14.3	19.2	39.1	20.2	54.9	24.1	4.8	17.8	19.6	37.0	21.1	1.3	3.2	44.5	31.6	27.9	26.1	22.9	1.0	31.1	13.9	50.0	21.6	24.1	170.9	32.8	27.0	25.6	1.5	29.4	28.2	14.7	2.7	27.5	25.2	69.2	14.8	33.8	32.8	14.0	19.7	32.2	7.2	10.7	15.6	22.2	12.4	26.1	29.6	12.0	12.5	10.4	24.1	42.5	30.3	31.4	12.7	18.8	8.2	13.2	7.1	65.7	11.6	10.8	42.1	6.2	19.2	25.6	32.8	24.5	21.6	21.0	27.9	24.8	22.5	13.5	8.6	72.7	19.1	16.6	18.6	56.4	10.6	10.2	20.5	80.6	16.5	48.3	10.4	8.7	12.0	19.2	24.1	48.2	39.6	13.4	13.7	211.3	40.2	29.1	29.3	22.1	19.7	193.0	214.3	81.3	24.5	19.2	15.9	1.1	1.4	1.7	1.3	0.7	1.5	1.1	0.9	1.2	1.0	1.0	0.5	0.8	5.3	1.1	1.4	5.8	1.3	0.7	15.7	22.6	21.8	24.9	24.1	4.8	1.3	3.2	1.0	1.5	2.7	14.0	21.8	6.4	18.6	21.9	29.8	37.2	10.9	10.6	25.6	82.3	25.2	19.7	42.0	17.2	16.2	1.8	173.0	5.0	72.5	60.6	0.0	7.7	2.5	26.4	26.0	24.0	21.5	11.0	28.7	11.1	4.9	25.1	25.0	43.1	3.8	9.0	22.9	13.2	18.0	70.7	18.8	32.2	8.2	25.4	64.1	4.4	31.4	35.5	14.2	20.6	17.7	19.0	33.0	13.0	20.2	25.8	46.3	32.4	44.6	19.7	17.2	3.4	9.1	85.3	98.6	48.8	46.1	5.1	10.7	16.6	38.1	15.3	33.1	11.0	14.0	19.3
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 15.5;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.4	0.0	1.8	0.1	0.1	0.0	0.8	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.6	0.3	0.0	0.1	0.0	0.6	0.5	0.0	0.7	0.0	0.5	0.0	0.5	0.1	0.3	15.5	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.3	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.8	0.1	0.6	0.6	0.5	0.5	0.2	0.3	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
MYOZ2	"C4orf5, CS-1, FATZ-2"	ENSG00000172399	"Myozenin 2"	Q9NPC6	4	119135832-119187789	"Disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 771.4;skeletal muscle: 225.5;tongue: 173.4"	"Cell type enriched"	"Detected in some"	51	"Cardiomyocytes: 2275.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;HSkMC: 2.3;SK-MEL-30: 6.2;U-87 MG: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA035763, HPA035764"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA035763: AB_2674770, HPA035764: AB_10696509"	"unprognostic (2.53e-1)"	"unprognostic (9.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.71e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.19e-7)"	"unprognostic (6.66e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.83e-2)"	0.6	0.3	0.2	0.0	0.3	0.0	2.1	0.1	0.5	0.7	0.0	1.0	0.0	2.0	0.3	1.0	1.0	0.3	771.4	0.2	0.3	0.7	0.1	0.9	0.3	0.2	0.2	0.6	0.1	0.0	0.2	0.2	0.1	4.8	0.1	0.0	1.8	0.3	225.5	0.5	0.4	0.8	0.2	0.6	0.6	1.0	0.3	0.3	0.3	173.4	0.1	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.2	1.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2275.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	20.8	0.0	0.0	3.4	2.2	0.0	44.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.7	0.0	0.2	0.0	2.9	0.0	0.0	6.6	6.9	22.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NTN1	NTN1L	ENSG00000065320	"Netrin 1"	O95631	17	9021510-9244000	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.1;heart muscle: 59.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 137.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 27.5;T-47d: 16.6;U-2 OS: 14.4;U-251 MG: 22.1;WM-115: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056419	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA056419: AB_2683124"	"unprognostic (2.72e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.33e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.07e-3)"	"unprognostic (8.31e-3)"	6.4	0.5	4.5	3.6	6.4	0.1	5.3	10.1	4.9	9.3	2.8	14.7	6.7	9.6	3.5	18.9	10.3	7.3	59.4	3.8	7.0	2.0	6.9	4.3	0.2	12.7	37.1	0.9	2.3	4.3	3.0	0.9	14.4	3.9	3.9	0.4	10.9	2.0	2.1	8.1	10.5	6.0	13.8	0.1	17.5	3.1	10.1	2.9	2.0	2.6	2.1	10.2	5.4	8.8	0.1	0.0	1.3	4.6	4.2	0.1	27.5	0.3	0.4	0.3	0.5	0.1	5.7	0.0	6.2	0.0	9.0	0.1	1.2	0.9	0.0	6.4	10.4	1.4	0.0	0.0	0.1	0.5	0.1	0.1	2.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	5.6	0.1	0.6	1.8	0.0	0.0	3.4	4.8	0.0	0.0	0.3	0.0	0.0	0.1	4.7	1.1	4.5	16.6	0.3	0.0	6.7	14.4	0.0	22.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	6.4	10.1	4.9	3.8	7.0	12.7	37.1	14.4	13.8	10.1	8.8	0.7	0.0	0.0	10.7	0.3	3.3	6.6	21.8	9.6	2.9	4.7	4.4	28.1	0.0	23.9	1.8	0.0	0.3	0.2	0.5	0.0	3.1	9.3	5.8	2.0	3.1	0.0	0.0	4.8	1.7	1.2	9.7	1.1	7.9	0.0	0.0	2.2	12.4	0.1	0.0	7.1	1.4	24.4	0.6	5.9	4.6	0.3	0.1	1.8	9.4	0.6	0.3	0.0	137.2	1.0	1.4	0.1	0.0	0.0	4.0	0.7	0.2	11.1	0.2	0.0	3.9	6.8	1.6	2.0	12.7	2.8	0.5	0.5	0.0	0.6	3.5
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88534033-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 7.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	6.5	0.7	4.3	1.2	3.4	4.2	2.8	6.0	5.5	4.0	1.8	0.5	0.9	2.0	1.3	0.4	4.3	1.0	0.7	3.4	3.4	2.3	4.5	0.7	0.9	0.7	1.2	1.1	0.4	0.3	0.1	0.6	1.4	0.9	0.4	4.8	1.6	0.7	1.3	1.5	0.9	0.4	0.4	1.1	0.8	1.3	3.6	0.5	1.3	0.1	0.5	0.4	0.3	5.1	1.5	2.6	1.0	1.0	0.1	0.7	0.7	2.6	0.7	0.3	0.5	0.6	1.0	0.6	1.1	0.3	0.7	1.3	0.4	0.1	0.9	0.4	0.8	1.3	4.0	1.0	0.4	0.7	1.1	0.5	0.2	0.3	0.2	0.4	0.0	0.9	0.9	2.7	0.7	0.7	0.7	1.2	1.4	0.5	0.7	0.5	0.5	0.9	10.4	0.8	0.6	0.4	1.6	0.8	0.5	0.7	1.2	0.6	0.9	0.9	1.9	1.5	0.6	0.9	0.8	0.7	0.7	0.9	0.7	2.1	0.3	0.8	0.6	0.1	0.6	0.2	0.3	0.7	0.0	0.3	0.6	0.7	0.8	0.5	0.1	0.3	0.6	0.3	4.3	3.4	6.0	5.5	3.4	3.4	0.7	1.2	1.4	0.4	3.6	5.1	0.2	0.0	0.0	1.3	0.1	0.0	1.9	0.7	1.2	0.2	7.5	3.2	0.3	4.3	0.1	1.8	0.0	0.2	0.0	0.0	1.9	0.8	11.4	39.1	4.3	0.8	0.0	0.0	1.2	0.2	1.3	0.8	0.0	13.9	0.0	13.2	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	4.4	0.9	0.2	0.0	0.0	0.0	0.5	0.0	1.0	0.7	0.2	0.0	2.2	0.1	0.4	0.0	18.6	0.2	0.8	0.0	0.3	1.3	0.4	1.6	0.0	0.1	1.1	0.3	12.7	0.0	2.2
NXPH3	NPH3	ENSG00000182575	"Neurexophilin 3"	O95157	17	49575871-49583827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Bipolar cells: 23.3;Fibroblasts: 7.6;Muller glia cells: 8.5;Peritubular cells: 14.3;Smooth muscle cells: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 11.4;BJ: 3.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 41.1"	HPA073819			Approved	"Vesicles,Mitotic spindle"	"Secreted in brain"	Yes	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Mitotic spindle"	"HPA073819: "	"unprognostic (2.39e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.59e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-3)"	3.9	0.9	1.8	1.0	1.8	0.0	2.9	16.4	3.5	9.0	0.7	11.0	0.4	12.0	0.6	1.5	7.0	1.7	2.9	3.5	0.5	0.4	0.1	2.7	0.5	6.3	3.8	5.2	0.6	1.3	7.5	1.3	6.4	5.9	0.3	0.6	3.1	4.7	1.2	2.3	1.7	2.5	0.1	1.0	3.4	1.6	3.9	0.3	1.4	2.0	0.3	8.9	6.9	3.0	0.0	0.0	0.1	0.0	0.0	0.2	11.4	3.2	0.4	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	16.4	3.5	3.5	0.5	6.3	3.8	6.4	0.1	3.9	3.0	0.5	0.0	1.3	14.0	0.0	0.4	0.3	0.2	0.6	23.3	0.9	0.5	1.7	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	2.5	0.2	3.2	7.6	0.0	0.5	0.0	0.0	6.4	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.4	0.0	4.4	0.3	1.8	0.0	4.2	8.5	0.0	2.5	0.5	0.0	0.0	14.3	0.7	0.3	0.0	0.0	0.0	1.2	0.0	0.8	8.9	0.1	1.3	0.0	1.1	0.1	0.2	0.1	0.0	0.1
OPCML	"IGLON1, OBCAM, OPCM"	ENSG00000183715	"Opioid binding protein/cell adhesion molecule like"	Q14982	11	132414977-133532519	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 39.2;parathyroid gland: 10.3;retina: 11.6"	"Group enriched"	"Detected in some"	34	"Excitatory neurons: 2120.9;Inhibitory neurons: 1900.4;Oligodendrocyte precursor cells: 3173.2"	"Cancer enriched"	"Detected in some"	4	"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BJ: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		7100000		"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.59e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.31e-4)"	"unprognostic (8.23e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.19e-1)"	0.2	0.4	13.2	0.1	16.6	0.0	0.1	22.3	39.2	0.4	0.0	0.1	0.1	0.6	0.1	0.4	0.5	0.2	0.3	18.4	3.1	1.4	0.0	0.0	0.0	0.0	5.1	0.3	0.0	10.3	1.3	0.0	0.0	0.1	0.1	11.6	0.2	0.6	0.1	0.1	0.1	0.5	0.2	0.7	0.2	0.4	9.6	0.0	0.1	0.3	0.0	0.1	0.1	13.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	9.4	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	16.6	22.3	39.2	18.4	3.1	0.0	5.1	0.0	0.2	9.6	13.4	0.0	0.0	0.0	25.5	0.0	0.1	0.0	0.0	0.0	40.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	6.7	0.0	0.0	0.4	0.0	0.0	2120.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.7	1900.4	0.0	0.0	0.3	0.4	14.9	0.0	0.1	0.0	69.3	0.0	1.3	0.0	3173.2	30.3	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	4.2	6.6	0.0	1.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247514	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 39.6;Oligodendrocyte precursor cells: 25.6;Squamous epithelial cells: 25.3;Suprabasal keratinocytes: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.4;hTCEpi: 34.0;RT4: 27.9;U-2 OS: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA047017: AB_2679904"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	3.4	1.7	5.8	1.4	5.7	0.6	5.3	3.8	7.9	9.6	6.8	6.0	1.8	6.5	2.7	18.0	6.2	3.3	2.9	9.3	7.8	7.0	3.5	2.9	2.5	6.3	5.8	6.2	2.1	2.1	3.8	5.5	5.5	5.7	2.0	1.8	4.5	5.9	1.9	38.1	3.0	5.4	4.6	2.0	2.7	2.1	8.3	5.3	18.0	1.0	4.3	5.6	12.0	5.9	3.0	4.3	17.7	13.4	0.6	0.7	12.9	3.3	0.7	2.9	0.4	1.2	1.2	0.0	1.4	1.5	5.1	13.4	6.4	19.2	2.8	0.5	5.7	0.2	3.5	10.4	0.8	4.0	36.4	5.7	34.0	0.3	1.8	2.2	1.4	4.2	1.4	0.8	4.3	5.0	3.6	0.4	5.3	1.4	5.2	0.1	11.7	1.5	0.5	27.9	7.4	7.7	4.1	2.2	20.0	8.6	2.6	3.4	1.1	5.9	28.8	2.2	1.6	0.9	1.2	0.3	1.9	0.9	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	5.7	3.8	7.9	9.3	7.8	6.3	5.8	5.5	4.6	8.3	5.9	3.3	3.2	0.6	7.5	0.7	39.6	13.7	11.0	18.8	1.3	4.1	10.3	2.8	1.5	2.3	3.7	0.0	0.6	9.7	0.4	0.0	0.4	0.5	9.8	10.1	8.2	0.0	0.0	6.5	0.2	9.5	4.1	0.5	3.3	0.0	3.1	10.8	1.5	0.8	0.0	8.5	0.7	8.2	0.9	6.5	0.7	1.8	0.8	12.4	15.9	0.0	2.0	0.0	25.6	4.8	0.8	0.0	1.9	3.6	6.6	0.0	7.6	2.6	2.5	19.7	1.9	13.6	1.5	6.0	25.3	63.9	0.4	8.0	2.0	0.6	13.4
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.1"	"Group enriched"	"Detected in many"	8	"Astrocytes: 311.8;Excitatory neurons: 1152.0;Inhibitory neurons: 882.3;Oligodendrocyte precursor cells: 917.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.4;RH-30: 120.4;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		340000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	1.8	3.2	10.5	5.2	14.6	0.0	3.0	0.0	33.7	23.9	0.0	19.2	3.2	16.9	25.1	14.3	9.7	8.1	19.1	23.7	50.1	2.0	1.0	2.9	1.4	13.0	14.3	4.7	0.9	1.1	0.2	0.2	14.3	10.6	7.8	3.4	0.8	18.2	0.6	11.6	5.0	22.1	3.9	18.6	11.4	1.0	46.3	1.4	4.1	0.4	1.2	16.3	5.9	11.8	0.0	1.1	14.4	20.1	29.5	28.5	0.0	3.8	0.0	1.9	0.9	1.9	26.5	0.0	0.1	0.2	0.0	15.3	1.3	38.5	3.4	0.0	43.4	0.1	26.8	0.0	30.4	0.6	0.0	17.2	8.8	1.0	10.7	17.5	7.5	0.0	0.0	0.0	9.0	0.1	0.0	0.1	8.8	9.3	4.0	0.0	120.4	0.0	0.9	65.2	0.9	0.2	0.4	1.2	1.3	8.2	1.8	6.9	0.0	24.1	6.2	6.7	0.0	0.0	0.0	0.0	18.8	0.1	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	14.6	0.0	33.7	23.7	50.1	13.0	14.3	14.3	3.9	46.3	11.8	1.1	0.0	0.0	311.8	0.3	85.0	92.4	25.7	46.7	46.8	0.7	9.0	83.2	0.0	13.7	64.4	0.0	0.1	0.0	0.3	0.0	0.6	16.9	66.8	8.4	7.6	0.0	0.0	1152.0	0.7	0.1	24.0	20.9	60.4	1.3	0.8	19.2	0.1	0.3	10.1	882.3	0.5	4.1	1.0	3.5	10.4	0.3	1.3	21.4	43.1	0.0	1.3	0.0	917.3	26.4	26.5	0.0	28.6	1.3	26.1	0.0	0.2	27.0	3.4	0.0	51.3	11.0	1.1	2.7	18.5	38.6	0.1	1.8	1.7	0.3	50.3
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465270-24550466	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoli	"HPA046583: AB_2679707, HPA072492: AB_2686526"	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	4.4	2.0	4.4	5.6	6.2	8.9	8.8	1.4	7.5	3.5	2.5	6.1	8.2	2.8	10.9	3.9	5.9	3.2	7.4	13.2	4.7	8.8	4.7	5.0	7.9	2.6	4.2	4.8	2.9	6.7	5.8	4.1	2.4	4.6	5.3	6.0	11.1	2.9	1.4	6.8	8.3	4.5	0.9	7.7	6.9	11.6	9.1	6.3	2.3	1.8	8.0	4.2	4.1	4.2	11.5	5.2	4.2	8.0	0.2	0.0	5.0	3.4	2.4	4.1	6.9	0.5	13.9	10.4	2.3	0.8	11.6	2.1	12.3	8.4	10.4	9.7	6.0	5.3	6.1	3.3	1.4	4.6	5.8	0.9	3.6	1.1	1.2	0.5	6.8	10.9	0.9	16.5	0.5	20.9	9.4	6.0	8.1	12.2	5.6	5.0	8.0	17.3	4.1	21.4	2.6	4.0	17.9	8.0	5.5	7.3	9.6	1.9	0.1	3.3	3.6	5.8	4.2	11.0	8.9	12.9	8.7	7.7	6.4	13.3	15.4	37.9	11.8	19.6	16.5	7.5	9.1	10.3	12.2	7.3	7.6	8.6	57.6	13.3	18.8	3.5	8.3	12.4	4.4	6.2	1.4	7.5	13.2	4.7	2.6	4.2	2.4	0.9	9.1	4.2	3.9	3.2	2.0	19.6	15.2	4.6	9.5	13.5	30.1	3.5	11.1	8.1	6.6	1.5	5.2	1.8	0.0	5.5	16.6	4.2	3.9	4.3	71.6	2.1	2.9	3.8	4.2	14.3	92.8	5.1	32.1	4.9	5.6	2.8	5.7	4.9	5.3	5.3	15.0	8.4	78.0	2.9	10.2	19.8	7.4	35.9	3.7	17.4	16.0	35.6	10.3	3.7	25.7	19.6	14.0	2.1	0.3	5.7	19.0	5.9	13.3	14.2	2.4	3.5	0.0	2.0	10.6	10.2	8.3	6.8	4.4	17.8	18.2	9.7	4.1	8.4
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.6;salivary gland: 57.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Region enhanced"	"Detected in all"		"cerebellum: 55.6"	"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	6.3	7.2	8.6	3.4	3.7	0.5	7.0	55.6	6.3	4.6	31.0	20.5	2.6	8.2	24.4	9.0	15.0	5.9	17.9	2.5	10.8	3.0	0.3	5.4	1.7	13.4	17.8	2.1	2.1	0.7	8.2	6.5	12.0	9.7	17.9	15.1	57.4	6.1	2.7	4.6	4.2	9.1	5.3	1.3	14.4	2.4	23.3	4.5	32.7	6.8	2.3	8.2	5.3	6.5	0.0	15.1	7.9	0.0	0.0	0.4	0.1	35.8	9.5	10.9	6.1	3.4	2.6	0.0	0.6	91.4	39.0	0.1	2.3	7.6	14.7	0.0	5.3	3.8	5.7	0.0	1.6	0.0	0.0	2.3	3.0	12.7	45.9	18.7	0.1	0.0	4.3	0.4	77.6	5.0	0.0	0.0	8.8	48.2	10.4	0.0	0.0	0.7	96.9	5.8	25.5	18.4	0.0	23.8	15.1	10.5	19.2	0.2	0.5	11.2	0.9	1.2	14.2	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	8.6	3.7	55.6	6.3	2.5	10.8	13.4	17.8	12.0	5.3	23.3	6.5	37.8	6.4	0.5	60.1	0.3	2.4	3.8	1.5	2.2	82.9	5.7	5.3	72.6	0.0	8.9	5.5	0.0	0.0	4.5	17.9	0.0	0.7	1.4	46.2	4.6	40.4	42.0	0.0	105.9	0.2	0.0	9.0	18.8	53.5	0.0	36.6	1.8	0.0	0.1	164.9	113.8	36.4	14.2	0.0	2.1	1.2	1.5	0.8	7.2	183.6	0.6	2.9	0.0	168.9	2.9	7.1	9.7	20.7	0.2	8.5	2.1	1.2	39.5	6.6	13.1	10.5	36.0	1.5	2.0	0.5	1.0	0.1	1.4	4.8	40.4	2.5
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633071	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 908.0;tongue: 448.5"	"Group enriched"	"Detected in many"	8	"Astrocytes: 201.8;Cardiomyocytes: 232.0;Hepatocytes: 64.2;Muller glia cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 41.9;HHSteC: 51.7;hTERT-RPE1: 85.4;LHCN-M2: 102.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	14.1	12.2	39.3	3.4	51.5	0.0	9.9	39.8	44.6	97.1	21.4	16.2	4.0	10.3	12.0	106.8	10.2	14.4	170.5	40.1	42.9	11.6	164.2	12.3	1.4	44.1	55.1	10.2	18.7	4.5	5.7	15.6	43.9	29.1	4.1	83.2	28.4	35.7	908.0	17.0	5.8	15.4	39.6	3.0	17.5	2.5	42.4	0.5	2.7	448.5	6.2	19.8	136.7	38.0	0.0	6.6	1.8	26.8	11.9	5.6	0.0	29.8	23.2	12.0	12.8	0.0	2.2	0.0	1.2	28.0	4.8	1.6	0.7	3.2	22.0	0.0	0.1	0.4	41.9	4.8	51.7	0.0	0.0	19.1	5.2	7.6	0.4	85.4	3.0	0.0	14.4	0.0	102.5	1.0	0.0	0.0	1.7	0.0	0.0	0.0	6.4	0.0	1.1	26.2	0.9	1.8	0.0	0.0	0.0	0.0	0.2	4.5	20.3	5.3	5.2	7.0	4.3	0.2	0.6	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	51.5	39.8	44.6	40.1	42.9	44.1	55.1	43.9	39.6	42.4	38.0	2.4	0.0	0.0	201.8	0.4	4.6	9.3	0.8	0.6	9.7	4.8	2.5	232.0	1.5	0.2	3.7	0.0	0.2	0.0	0.3	7.9	3.1	0.1	0.3	0.7	3.5	10.1	0.0	1.7	11.4	0.5	11.9	0.0	0.6	0.0	0.4	2.5	64.2	1.4	18.5	3.0	0.5	2.0	1.6	1.5	0.1	2.8	0.6	12.4	5.6	0.0	133.1	0.0	3.5	0.5	4.0	0.1	7.5	0.0	2.5	0.0	1.8	0.4	12.8	0.0	9.4	18.6	0.7	1.7	5.4	4.0	0.3	0.7	0.1	0.1	0.7
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;liver: 86.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.6	10.0	11.0	1.4	21.4	0.0	1.8	24.6	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.2	1.9	15.7	23.1	12.4	4.7	86.8	1.2	2.8	18.7	17.3	7.4	15.5	0.1	4.0	0.4	13.9	0.5	2.7	21.2	0.3	0.4	3.6	0.7	2.6	0.8	10.6	7.1	2.1	5.4	30.0	0.2	7.6	2.1	0.7	1.0	0.7	38.2	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.4	24.6	18.2	23.1	12.4	18.7	17.3	13.9	10.6	30.0	38.2	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 104.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	30.7	45.4	8.9	6.8	21.0	0.0	42.5	5.9	16.3	32.0	3.5	37.0	4.1	104.7	50.3	15.1	72.7	11.2	14.0	10.2	12.3	37.0	2.5	16.5	4.3	20.7	12.8	29.0	9.8	4.8	1.4	33.3	21.2	17.0	9.3	0.8	10.2	77.5	5.4	10.2	18.0	83.9	7.7	31.4	20.1	9.0	12.8	2.6	5.8	5.8	2.7	17.4	20.0	9.0	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	21.0	5.9	16.3	10.2	12.3	20.7	12.8	21.2	7.7	12.8	9.0	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RND2	"ARHN, Rho7, RhoN"	ENSG00000108830	"Rho family GTPase 2"	P52198	17	43025231-43032041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 64.2;choroid plexus: 17.8;testis: 37.2"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 590.2"	"Group enriched"	"Detected in many"	5	"glioma: 44.4;testis cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;AN3-CA: 15.5;HAP1: 12.1;NTERA-2: 17.2;SH-SY5Y: 10.4;SuSa: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077757	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA077757: AB_2732361"	"unprognostic (2.19e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.55e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.22e-4)"	"unprognostic (7.85e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.13e-3)"	"unprognostic (9.92e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.57e-2)"	0.6	3.0	30.8	0.2	41.7	0.2	1.0	46.5	29.9	2.2	17.8	4.1	0.3	3.6	2.5	1.1	2.0	0.8	2.2	23.1	48.4	1.5	4.1	0.5	0.2	64.2	59.0	3.7	0.6	5.6	7.0	0.1	52.4	2.6	0.4	3.9	0.8	3.7	0.5	2.2	1.2	2.4	47.8	0.1	1.3	37.2	46.3	0.4	6.5	0.2	0.3	2.1	1.6	38.8	0.0	0.3	12.0	15.5	0.9	0.6	0.3	0.5	0.7	2.1	1.6	1.9	0.2	0.1	2.8	1.6	0.7	0.1	12.1	0.2	1.8	0.0	6.2	0.0	0.2	0.2	0.9	0.1	0.1	0.8	0.1	2.4	0.1	0.3	0.2	1.3	3.1	0.1	0.0	0.5	4.9	0.2	17.2	0.0	0.1	0.9	0.0	0.1	0.2	0.0	3.3	10.4	0.0	0.2	0.1	7.9	2.3	0.0	0.1	0.3	0.4	0.1	0.0	1.1	3.3	0.2	1.9	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	30.8	41.7	46.5	29.9	23.1	48.4	64.2	59.0	52.4	47.8	46.3	38.8	1.5	0.0	1.5	2.0	0.1	1.3	4.8	0.6	6.8	2.8	2.0	3.3	2.1	1.5	2.0	3.7	0.0	2.1	0.0	0.1	5.9	1.2	136.3	1.9	12.6	1.2	0.0	0.0	2.2	0.8	1.9	3.2	0.0	1.0	1.3	10.5	1.4	3.3	0.6	5.0	7.2	0.0	0.0	0.6	0.7	590.2	5.0	0.8	1.8	1.0	0.0	27.2	1.0	11.6	1.6	0.3	0.1	4.5	0.1	1.6	0.0	2.3	6.5	3.7	0.0	6.2	2.9	38.3	6.1	0.8	1.8	1.6	0.6	2.6	0.1	1.6
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165843-64372869	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 90.5;Inhibitory neurons: 151.6;Oligodendrocyte precursor cells: 162.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favorable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	5.4	5.1	3.2	1.5	3.9	0.3	3.6	2.6	5.1	4.1	2.9	3.3	1.7	7.7	7.7	4.2	4.9	4.2	7.0	2.8	8.2	8.1	4.5	3.7	1.3	3.9	5.8	7.6	4.2	25.3	3.5	0.6	4.7	7.3	1.3	6.0	4.6	10.6	2.7	4.1	1.4	5.7	4.4	3.0	2.6	3.4	6.6	0.7	14.0	4.1	0.9	3.3	2.3	4.5	0.0	0.1	1.4	0.0	0.0	0.0	0.3	1.2	0.5	1.2	0.7	0.0	0.1	0.0	0.1	0.9	0.7	0.2	0.0	0.5	0.2	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.3	0.1	3.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.6	0.0	1.4	0.1	3.7	29.4	2.1	0.3	0.3	0.1	0.0	0.3	0.0	1.8	1.5	0.1	0.1	0.0	3.5	0.1	3.3	0.0	0.0	0.0	0.6	0.0	3.9	1.2	0.6	1.7	0.6	0.2	0.9	0.5	1.0	1.1	0.2	0.8	1.4	1.3	1.0	0.8	0.3	0.4	0.7	0.0	3.2	3.9	2.6	5.1	2.8	8.2	3.9	5.8	4.7	4.4	6.6	4.5	9.5	16.0	12.3	51.6	0.5	4.6	8.9	1.3	7.4	16.6	8.1	4.2	10.9	10.0	4.9	16.5	14.6	0.0	0.0	0.0	7.9	5.8	12.5	14.2	6.1	6.3	1.2	0.0	90.5	2.6	0.1	7.9	6.1	32.9	0.0	5.7	14.3	5.9	0.1	11.8	151.6	1.9	0.0	0.6	1.1	8.8	34.5	0.5	5.4	32.8	0.0	30.1	0.0	162.3	50.1	3.1	2.7	25.2	0.0	6.4	1.2	15.9	1.9	16.9	39.5	24.2	20.4	18.9	12.0	2.9	7.4	0.0	0.3	4.1	1.6	4.5
SALL2	"Hsal2, KIAA0360, ZNF795"	ENSG00000165821	"Spalt like transcription factor 2"	Q9Y467	14	21521080-21537216	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Bipolar cells: 13.9;Horizontal cells: 13.5;Muller glia cells: 11.2;Oligodendrocyte precursor cells: 10.6"	"Cancer enhanced"	"Detected in many"		"glioma: 16.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 109.2;NTERA-2: 85.7;SuSa: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004162	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	Nucleoplasm	"HPA004162: AB_2667155"	"unprognostic (5.73e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	3.9	5.4	40.2	1.4	37.7	0.2	5.5	43.2	31.0	13.1	16.6	13.3	1.7	13.5	6.3	2.9	12.7	3.2	5.4	29.4	43.7	6.2	0.9	4.5	1.7	41.3	45.2	17.2	4.3	20.6	27.0	1.2	36.9	7.0	2.1	16.9	3.1	9.2	1.5	2.6	6.7	9.5	39.2	2.8	6.0	1.6	49.1	6.5	10.5	2.8	1.7	8.7	6.3	28.7	0.1	2.4	109.2	24.2	1.9	1.6	0.0	2.1	2.7	7.1	7.2	2.3	1.2	0.1	2.2	3.2	3.1	0.2	24.5	2.7	10.0	2.0	12.5	0.0	0.7	2.2	3.2	0.0	0.1	7.3	0.9	3.4	0.0	18.4	2.2	10.9	16.6	0.0	6.2	2.1	16.0	0.1	85.7	0.1	0.5	14.3	2.3	0.0	8.3	11.6	30.4	17.3	0.0	0.6	0.3	36.2	9.2	0.2	0.0	0.9	11.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.5	0.5	0.1	40.2	37.7	43.2	31.0	29.4	43.7	41.3	45.2	36.9	39.2	49.1	28.7	0.8	3.2	3.6	13.4	0.0	0.6	0.6	1.1	8.0	13.9	3.4	2.8	0.9	2.8	1.5	5.5	8.4	0.1	0.2	0.0	1.9	1.8	0.3	0.5	3.2	1.0	0.0	0.4	2.5	0.0	0.1	3.9	0.0	0.4	0.0	7.2	2.5	0.1	0.1	13.5	9.3	0.0	4.1	0.0	0.3	0.7	5.0	0.2	0.0	0.0	0.0	11.2	0.0	10.6	2.6	0.3	0.0	6.0	0.2	0.4	0.0	0.8	0.0	2.8	0.0	3.9	3.0	0.0	0.5	1.0	0.6	0.1	0.8	3.9	0.0	0.1
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50130160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4"	"Cell type enriched"	"Detected in many"	4	"Bipolar cells: 56.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HEL: 8.6;HMC-1: 28.0;SH-SY5Y: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: AB_2681662"	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	0.9	1.4	14.9	0.8	14.0	0.3	0.5	19.4	15.4	1.6	0.0	1.0	0.2	3.1	0.8	0.5	0.5	0.3	1.2	15.3	11.0	3.1	0.8	6.0	0.3	9.4	8.8	1.3	0.2	0.7	3.4	0.7	8.5	3.0	0.1	1.3	0.1	0.7	1.4	0.3	0.9	0.4	6.0	1.7	1.1	2.1	11.2	0.1	0.9	0.5	0.5	1.8	1.1	10.1	0.0	0.2	4.2	0.0	1.1	0.3	0.0	3.0	1.1	0.1	0.0	0.6	0.0	0.1	4.1	1.3	0.0	0.1	0.3	0.0	0.1	12.7	0.1	8.6	0.3	0.0	0.7	0.0	28.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.3	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	12.9	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.6	1.6	0.3	0.1	0.2	0.0	0.1	2.2	0.1	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	14.0	19.4	15.4	15.3	11.0	9.4	8.8	8.5	6.0	11.2	10.1	0.6	0.0	0.5	6.2	0.0	0.4	0.1	0.2	0.6	56.1	0.2	0.3	1.1	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.2	3.1	0.0	1.4	6.1	12.7	2.7	8.3	0.4	0.2	2.3	0.5	0.1	2.5	0.1	8.2	0.3	0.1	11.8	7.2	0.3	0.0	0.6	1.0	2.2	1.5	5.7	0.0	1.0	2.0	2.2	0.0	2.5	0.4	0.2	0.1	3.4	0.2	0.0	0.3	1.1	0.0	4.6	0.0	0.1	2.8	1.5	1.1	0.2	0.1	0.4	0.2	0.7	0.1	0.1
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
SELENOM	"SELM, SEPM"	ENSG00000198832	"Selenoprotein M"	Q8WWX9	22	31104772-31120069	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 373.6;Breast myoepithelial cells: 436.2;Collecting duct cells: 309.0;Distal tubular cells: 309.1;Endometrial stromal cells: 349.5;Exocrine glandular cells: 586.6;Smooth muscle cells: 225.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 154.8;T-cells: 233.0"	"Cell line enhanced"	"Detected in many"		"BJ: 152.2;BJ hTERT+: 143.8;HHSteC: 183.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008667, HPA019601"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		170000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"CAB008667: AB_1622762, HPA019601: AB_1856666"	"unprognostic (5.29e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.51e-3)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.19e-2)"	241.8	95.4	126.7	55.7	126.7	2.9	239.8	127.3	170.7	458.8	189.9	575.4	37.2	600.2	14.8	86.1	437.8	28.6	227.2	130.0	149.3	162.5	36.7	157.5	25.9	137.1	138.6	262.4	154.3	94.7	241.1	32.2	131.0	339.6	16.4	8.1	198.8	140.1	109.9	114.8	193.9	85.3	139.6	97.6	285.6	42.1	142.1	10.2	225.8	18.6	15.3	462.3	290.7	132.3	12.8	25.7	7.4	42.7	68.8	80.5	82.2	152.2	143.8	69.2	50.0	0.8	2.0	1.6	30.9	89.9	31.2	1.2	6.9	9.2	4.7	7.0	25.6	2.7	7.8	13.3	183.7	0.0	13.1	78.5	27.1	33.1	12.6	33.1	9.0	2.2	2.4	14.7	17.9	6.6	0.5	1.4	9.6	11.8	27.3	0.1	0.1	18.1	11.1	0.1	16.2	35.7	47.3	41.6	0.7	2.5	57.5	0.9	30.9	20.8	59.0	77.8	0.1	13.2	6.5	1.0	83.1	0.2	13.8	18.3	10.5	5.1	105.3	19.9	137.9	154.8	174.5	127.0	6.4	129.5	233.0	137.8	8.2	39.1	40.1	2.5	179.0	102.6	126.7	126.7	127.3	170.7	130.0	149.3	137.1	138.6	131.0	139.6	142.1	132.3	168.6	54.5	126.5	0.0	38.8	0.0	0.0	0.0	0.0	0.0	373.6	436.2	0.0	0.0	32.2	309.0	0.0	11.7	23.2	0.0	309.1	101.2	0.0	22.8	349.5	61.8	0.0	0.0	0.0	586.6	149.5	161.3	0.0	18.1	30.3	30.8	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	42.9	0.0	0.0	0.0	0.0	166.2	0.0	0.0	22.3	0.0	0.0	152.5	20.4	0.0	0.0	0.0	225.6	0.0	0.0	0.0	0.0	23.4	24.8	30.5	0.0	0.0
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 130.6;skeletal muscle: 131.2"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 250.2;Oligodendrocytes: 151.7;Urothelial cells: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 132.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	11.9	8.0	33.4	9.8	45.3	3.0	12.1	55.4	37.1	15.8	130.6	22.8	46.7	18.5	9.9	32.7	24.5	15.1	63.2	30.1	48.7	17.5	39.7	15.1	6.5	46.5	56.5	8.1	51.6	15.0	10.5	13.5	47.5	13.6	19.0	7.5	87.9	17.6	131.2	23.3	18.8	17.9	42.7	7.4	15.1	15.9	67.8	11.9	82.8	57.6	9.1	22.0	21.7	52.8	52.7	14.3	19.0	16.0	10.4	8.8	41.1	46.9	80.8	23.9	58.7	38.9	132.9	17.4	53.6	42.1	13.5	81.1	11.4	45.2	41.6	4.3	8.7	27.8	4.8	22.0	14.9	9.9	12.3	9.5	40.2	24.7	22.7	16.7	12.0	13.7	27.2	14.0	47.3	14.4	18.1	16.1	19.2	50.5	8.8	14.9	20.9	18.5	21.4	47.5	5.1	19.2	12.8	21.8	12.8	15.0	17.5	17.3	34.9	50.0	17.4	12.3	25.7	9.0	22.2	12.6	15.8	19.5	28.3	3.2	2.2	0.2	3.6	1.6	4.3	2.1	4.0	3.5	3.7	2.1	4.8	3.7	0.8	6.8	1.3	2.0	4.1	3.1	33.4	45.3	55.4	37.1	30.1	48.7	46.5	56.5	47.5	42.7	67.8	52.8	11.1	28.9	18.6	51.6	9.1	98.9	250.2	22.7	96.2	13.4	21.7	14.9	60.2	14.3	21.7	16.5	16.7	23.9	14.3	76.2	13.7	29.6	10.4	79.9	15.8	18.9	12.0	6.9	88.9	31.4	23.7	15.8	15.8	61.2	3.8	17.1	6.4	30.7	10.2	6.7	88.4	11.5	18.3	7.7	12.2	10.0	7.2	10.2	10.6	78.7	7.3	14.4	14.4	63.3	151.7	47.4	35.8	11.7	8.6	76.6	20.0	7.3	57.6	10.2	6.6	22.9	28.3	5.2	7.2	73.9	74.3	25.4	14.2	23.7	12.5	170.3
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 126.4;skeletal muscle: 129.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.5;Peritubular cells: 88.4;Sertoli cells: 65.7"	"Cancer enhanced"	"Detected in all"		"glioma: 28.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;granulocytes: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	20.7	40.3	104.0	5.0	101.9	7.1	22.1	70.7	126.4	25.0	59.8	25.2	3.0	22.8	14.7	8.4	30.6	14.6	78.9	105.3	90.4	18.8	2.8	18.8	4.6	79.5	89.8	37.6	14.3	27.2	42.2	5.7	83.2	27.7	3.8	10.0	14.3	23.2	129.0	11.5	11.0	13.4	72.4	9.2	18.3	17.4	99.9	1.9	18.1	69.4	2.5	22.7	18.2	84.8	0.8	6.1	19.6	69.3	30.0	13.3	1.6	13.3	13.0	7.5	4.3	4.5	4.2	7.7	4.7	20.4	3.0	1.3	15.7	1.3	3.0	2.4	10.2	0.0	4.5	1.4	25.9	0.4	12.5	31.8	1.8	2.4	0.2	32.7	1.5	19.5	16.4	2.5	39.5	8.3	1.3	10.3	6.1	2.0	2.5	0.5	31.7	0.3	6.6	0.0	11.2	22.6	12.4	2.1	9.5	3.1	2.0	19.7	2.6	6.1	7.7	15.7	4.9	16.1	0.0	6.5	14.2	17.6	21.6	0.4	5.5	0.0	0.1	1.3	0.1	0.1	0.5	0.0	1.6	0.0	0.3	0.5	1.9	0.0	0.2	0.0	0.4	1.3	104.0	101.9	70.7	126.4	105.3	90.4	79.5	89.8	83.2	72.4	99.9	84.8	7.5	6.4	21.7	33.6	0.7	10.7	38.3	3.1	47.8	15.2	28.5	29.6	67.5	21.5	4.6	11.0	4.2	0.4	1.2	0.2	31.3	24.8	2.5	3.9	24.4	5.2	3.5	1.3	16.7	2.6	0.5	28.0	1.5	3.4	2.5	44.3	2.9	0.5	3.6	11.8	23.9	0.3	0.0	17.0	5.7	14.0	50.7	16.0	7.2	8.4	19.7	23.7	0.0	16.1	7.4	2.8	0.1	88.4	0.1	14.6	0.0	2.1	4.7	5.7	65.7	40.9	56.9	1.7	20.0	1.5	4.7	1.1	4.7	22.8	0.2	9.0
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766719	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 65.9"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 145.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 11.5;HaCaT: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026871, HPA072699"	Enhanced		Supported	Cytosol		NA	NA		1200000		"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA026871: AB_1857536, HPA072699: "	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.9	0.2	0.8	0.9	0.5	0.7	0.9	0.1	0.6	1.0	0.0	2.8	0.3	0.9	1.5	0.8	1.3	1.0	0.4	1.3	0.1	0.4	14.7	0.5	3.9	0.4	0.0	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.4	0.3	0.4	0.0	0.2	0.3	0.6	0.2	0.1	65.9	0.4	2.2	0.3	0.0	1.1	0.0	0.4	0.7	0.5	0.1	0.2	0.5	0.5	0.1	0.0	0.0	11.5	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.8	0.3	0.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.4	0.6	0.3	0.0	0.8	0.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.6	1.3	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.7	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.1	0.0	0.0	4.0	0.0	0.0	2.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	145.6	4.1	0.1	0.0	1.9	0.0	0.0	11.6	0.7	12.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0
SULF1	"hSulf-1, KIAA1077, SULF-1"	ENSG00000137573	"Sulfatase 1"	Q8IWU6	8	69466624-69660915	"Predicted intracellular proteins"	Apoptosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 180.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 214.2;Fibroblasts: 52.8;Inhibitory neurons: 63.0;Late spermatids: 101.4;Muller glia cells: 162.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 315.4;BJ hTERT+: 420.2;fHDF/TERT166: 520.0;U-2197: 126.1;WM-115: 175.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054728	Supported				"Intracellular and membrane"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"HPA054728: AB_2682586"	"unprognostic (2.89e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (8.91e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.69e-2)"	24.1	2.6	8.1	24.4	6.4	0.0	8.0	2.2	2.7	14.5	180.3	36.4	10.0	28.7	14.2	18.3	11.3	30.6	14.2	6.4	7.4	9.9	1.8	9.7	6.3	1.9	18.2	14.2	3.5	1.4	9.7	4.2	5.8	50.8	20.6	60.0	4.3	41.9	2.2	2.6	14.1	72.6	3.4	2.2	4.0	2.2	18.6	2.2	19.9	11.2	4.8	32.1	9.5	3.0	0.0	0.0	57.3	0.0	6.2	27.3	0.4	315.4	420.2	10.9	1.7	0.0	1.2	0.5	0.2	520.0	0.0	0.4	0.8	0.5	2.1	0.0	1.1	0.0	1.0	0.0	1.5	0.1	0.5	35.6	3.7	18.2	6.7	15.2	1.4	0.0	0.0	0.6	8.5	1.3	0.0	0.0	6.5	0.0	0.4	0.0	23.2	0.9	0.0	0.0	1.1	0.0	0.0	0.5	0.0	22.6	76.7	0.0	0.0	29.0	0.8	126.1	0.0	0.1	0.0	0.1	0.1	0.1	175.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.4	2.2	2.7	6.4	7.4	1.9	18.2	5.8	3.4	18.6	3.0	10.6	9.6	6.2	3.9	0.1	0.9	2.7	7.8	26.2	1.8	1.3	13.7	4.3	2.8	13.5	5.5	0.0	0.3	0.0	0.0	0.0	0.3	214.2	1.0	30.5	13.5	1.2	2.7	9.6	0.0	0.0	52.8	0.0	1.0	0.0	0.1	15.4	0.5	0.3	0.0	63.0	0.3	0.0	0.6	1.3	101.4	6.5	0.8	0.0	1.0	0.0	162.8	0.0	3.5	0.6	0.7	0.1	1.9	0.0	1.4	0.0	0.1	5.5	6.5	0.0	5.2	42.4	1.6	1.4	2.5	0.3	0.3	0.3	0.1	0.0	0.4
SUSD2	"BK65A6.2, FLJ22778, W5C5"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181487-24189106	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 99.8"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	29	"SK-BR-3: 898.7"	"Low region specificity"	"Detected in all"							HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		6800000		"Cluster 19: Lung - Lung function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	12.1	9.6	4.9	1.9	2.8	0.2	9.5	1.7	5.8	13.6	2.2	4.8	12.8	9.8	0.5	2.8	15.0	1.8	12.5	1.6	5.3	32.6	2.9	99.8	2.2	22.9	6.9	5.4	4.3	1.5	7.1	3.6	26.5	5.6	1.0	0.1	4.7	5.6	2.2	28.2	34.6	3.4	6.8	3.6	6.3	3.2	13.2	0.8	17.8	1.4	1.3	5.4	11.0	10.0	5.1	10.4	0.1	0.0	18.8	24.3	0.8	2.4	0.1	0.1	0.0	7.8	0.6	1.4	21.5	0.5	0.4	1.4	0.1	0.5	0.0	0.6	0.3	0.0	0.4	30.6	8.0	0.0	0.3	21.5	0.4	0.1	6.2	0.0	0.1	0.0	0.5	0.3	0.0	9.1	0.3	0.4	0.7	2.5	0.3	0.3	0.0	2.5	0.1	0.2	1.7	13.5	0.7	898.7	0.2	3.6	3.0	0.0	0.0	0.1	0.9	0.7	0.1	1.1	1.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.8	1.7	5.8	1.6	5.3	22.9	6.9	26.5	6.8	13.2	10.0	1.7	250.0	151.5	0.3	0.6	0.3	0.3	2.6	0.0	0.0	3.4	3.4	6.8	0.0	20.9	1.8	0.0	13.8	0.3	0.7	5.9	0.1	0.0	1.3	0.7	1.1	1.8	0.0	0.2	0.0	0.7	6.7	0.5	1.3	3.8	0.1	2.9	0.5	1.1	0.0	0.1	5.5	2.0	0.0	0.3	0.4	0.6	0.8	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	154.9	27.8	3.6	0.0	0.0	0.6	22.1	1.7	1.3	0.7	2.7	26.4	1.1	0.0	1.6	0.6
SYNDIG1	"C20orf39, DSPC2, FLJ14220, IFITMD5, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469629-24666616	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;heart muscle: 26.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 157.4;Microglial cells: 472.2;Oligodendrocytes: 214.3"	"Cancer enhanced"	"Detected in many"		"glioma: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 15.4;RH-30: 43.4;RPMI-8226: 43.6;SCLC-21H: 10.0;U-87 MG: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA044271: AB_2732515, HPA059267: AB_2683961"	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.16e-6)"	"unprognostic (1.40e-3)"	1.8	0.9	23.7	1.5	23.2	0.0	0.5	27.6	26.8	3.2	8.6	0.8	1.2	3.2	0.7	0.2	4.2	8.8	26.9	21.1	21.0	4.9	0.0	0.7	2.0	28.4	23.0	0.9	0.7	0.2	0.7	0.2	28.4	3.3	0.9	1.8	0.3	12.3	0.1	0.2	2.1	2.2	27.8	0.7	1.6	0.8	25.3	1.6	4.8	0.1	2.4	1.7	2.0	36.4	0.0	0.3	2.6	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	15.4	0.0	0.8	0.0	0.0	2.6	0.0	0.0	0.0	43.4	43.6	0.0	0.0	10.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	23.2	27.6	26.8	21.1	21.0	28.4	23.0	28.4	27.8	25.3	36.4	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.2	0.7	0.6	1.2	0.0	0.0	157.4	0.0	0.0	2.0	0.0	0.8	0.0	21.9	0.0	0.0	0.1	3.3	69.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	472.2	0.0	1.9	0.0	41.7	214.3	1.5	0.0	7.2	0.0	0.0	0.0	5.9	0.0	0.5	0.0	0.5	1.4	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"	Q07654	21	42311667-42315651	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 305.8;intestine: 355.3;salivary gland: 340.2;thyroid gland: 416.7"	"Cell type enriched"	"Detected in many"	10	"Intestinal goblet cells: 33890.3"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 765.0"	"Region enriched"	"Detected in single"	6	"midbrain: 1.9"	"Immune cell enriched"	"Detected in single"	9	"eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0"									"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	NA	151000000	6500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: AB_2674636"	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	11.5	5.9	0.1	27.8	0.1	2.2	26.3	0.3	0.2	305.8	0.1	355.3	208.0	2.8	0.5	22.7	49.8	82.8	3.5	0.1	0.1	5.7	6.6	9.9	3.5	0.1	1.9	3.5	6.1	0.0	1.3	0.1	0.2	9.8	305.8	0.1	340.2	1.6	0.9	6.7	290.6	8.4	0.1	23.1	7.4	0.5	0.2	1.8	416.7	1.7	0.9	3.6	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.7	0.0	0.7	0.1	126.6	12.1	0.0	9.0	0.3	0.1	0.0	16.1	0.1	0.0	1.7	0.0	0.0	27.8	0.0	105.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	1.9	0.2	0.1	0.2	0.1	36.9	16.0	25.3	0.0	15.4	41.6	15.1	196.3	3.4	0.1	804.5	444.7	21.6	919.3	595.9	22.0	0.0	0.6	3.4	2188.7	0.0	9.4	0.5	29.3	1.4	322.8	770.9	0.0	0.0	67.8	0.7	21.5	71.4	11.4	59.2	2.0	170.3	5.8	2.1	5.0	0.0	33890.3	3263.2	3.4	42.4	9.0	2.5	2.8	96.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	1855.5	7.9	6.1	73.0	2788.7	0.1	453.2	0.1	0.0	1.1	28.2	1.0	0.3	4.3	38.6	0.8	14.9	0.6	1376.3	107.7
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 100.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	65.5	17.0	4.8	22.7	5.1	1.0	52.8	4.6	6.9	119.0	4.4	264.4	14.5	265.6	12.4	38.2	143.2	14.4	48.5	4.6	4.7	26.6	9.7	54.7	4.8	5.6	4.6	78.6	8.2	8.6	8.2	19.7	5.0	87.6	23.9	0.7	21.0	80.8	13.1	28.5	61.7	106.1	4.7	33.0	78.5	10.2	5.1	1.4	26.8	10.5	4.9	171.1	73.6	4.4	13.3	16.6	25.9	0.0	25.4	46.1	0.3	70.8	64.8	43.6	30.1	6.6	4.5	0.0	65.1	62.3	29.1	20.6	6.0	13.3	56.4	0.1	0.3	17.5	29.1	3.7	67.4	0.0	19.8	31.1	18.7	27.5	16.3	100.0	29.2	0.0	1.5	0.0	51.9	0.1	0.0	1.6	1.4	1.4	16.2	0.0	30.9	0.1	12.5	6.6	0.0	19.0	27.5	0.2	14.1	20.9	0.1	1.7	82.4	79.8	19.2	21.4	31.8	0.1	0.1	0.2	34.9	0.8	49.6	9.5	0.0	0.1	0.2	0.0	0.3	0.9	0.9	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.3	1.6	1.3	4.8	5.1	4.6	6.9	4.6	4.7	5.6	4.6	5.0	4.7	5.1	4.4	76.9	6.4	4.8	0.0	0.4	12.6	23.9	34.8	14.8	0.4	4.1	71.5	13.4	5.7	3.4	7.3	0.0	1.2	1.5	1.8	7.9	33.3	1.2	3.6	76.2	48.8	0.0	11.0	0.1	22.5	1.2	64.4	4.6	2.9	6.3	35.3	29.6	0.3	14.6	0.0	0.1	4.7	0.0	0.3	15.4	3.3	92.2	9.3	40.9	2.8	4.2	7.0	0.0	3.5	0.1	28.4	2.2	179.0	1.4	20.1	13.3	19.7	1.1	1.4	223.5	17.4	176.0	1.5	3.6	1.9	11.2	1.8	2.6	20.3	5.3	4.6
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 86.9;smooth muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (3.51e-4)"	9.4	3.8	9.2	7.1	8.3	0.8	5.7	3.5	8.2	13.7	4.3	8.6	1.6	86.9	6.0	20.4	45.6	6.2	6.3	15.3	6.6	2.7	2.4	15.5	3.9	5.5	8.5	15.9	2.4	0.8	3.0	2.0	4.8	6.8	8.6	0.3	3.9	5.4	4.7	23.1	7.9	84.8	4.3	19.9	5.8	4.4	6.6	0.9	5.4	3.5	3.2	18.6	15.1	5.6	0.1	0.4	0.1	0.2	35.0	87.8	0.4	0.3	0.1	1.0	1.6	0.1	1.0	0.1	1.5	5.0	11.2	0.1	1.2	0.8	0.4	0.1	0.7	0.0	2.4	5.9	9.1	0.3	1.9	32.5	7.1	6.7	26.8	5.8	78.7	0.1	0.1	0.1	74.5	0.9	0.0	0.6	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.1	0.1	0.9	0.5	0.6	105.5	8.0	0.5	26.5	2.3	0.4	0.0	0.1	16.7	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.6	0.3	0.2	0.2	0.0	0.0	9.2	8.3	3.5	8.2	15.3	6.6	5.5	8.5	4.8	4.3	6.6	5.6	1.2	0.0	0.5	4.6	0.0	3.3	1.1	0.4	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.3	2.3	1.7	3.9	10.3	0.0	4.5	0.4	0.0	5.8	0.0	0.1	0.0	7.1	1.8	0.3	2.9	0.0	14.4	3.3	2.0	2.9	10.8	0.7	9.0	3.5	1.8	1.0	0.6	0.1	0.0	1.0	2.6	0.1	1.5	5.3	0.1	0.4	0.0	0.1	1.3	0.2	6.6	1.6	9.3	23.7	0.8	0.3	8.4	0.0	0.1	0.1	1.5	0.5
TOX	"KIAA0808, TOX1"	ENSG00000198846	"Thymocyte selection associated high mobility group box"	O94900	8	58805412-59119147	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 52.4"	"Group enriched"	"Detected in many"	5	"Astrocytes: 316.3;Excitatory neurons: 198.3;Inhibitory neurons: 155.0;Oligodendrocyte precursor cells: 455.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 36.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.5;NK-cells: 18.4;T-cells: 36.6"	"Cell line enhanced"	"Detected in many"		"JURKAT: 75.9;MOLT-4: 149.1;SH-SY5Y: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018322, HPA073241"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA018322: AB_1858199, HPA073241: AB_2686584"	"unprognostic (7.60e-4)"	"unprognostic (6.16e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.73e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	0.7	1.0	7.1	5.8	9.3	2.9	1.0	0.1	10.7	1.8	0.0	11.4	9.5	1.3	0.4	3.3	0.8	4.6	0.7	6.4	8.0	3.0	1.1	4.6	18.2	2.0	4.4	5.7	1.4	2.4	1.8	1.3	2.2	2.0	8.6	6.0	1.6	1.0	0.1	0.5	10.3	2.5	0.0	5.5	7.9	6.3	5.8	52.4	1.1	0.6	18.9	2.0	1.4	4.9	0.9	0.2	15.7	0.0	1.6	3.5	0.0	3.3	7.5	1.8	0.3	0.0	0.0	0.0	0.0	14.4	0.8	1.2	3.9	0.0	0.4	0.5	1.5	0.0	2.8	0.0	12.7	2.8	0.7	1.9	0.5	2.3	2.9	1.0	25.9	75.9	0.0	0.0	1.2	0.0	149.1	0.0	2.7	0.2	0.4	3.1	10.7	0.1	0.4	0.4	14.3	43.8	0.0	0.1	0.0	3.6	0.0	0.0	0.2	3.9	1.8	12.9	4.4	0.0	0.0	9.9	0.5	0.1	2.8	21.5	0.2	3.2	12.1	0.0	5.5	5.4	8.6	18.2	1.4	1.3	3.3	9.7	0.3	18.4	0.0	0.0	36.6	5.6	7.1	9.3	0.1	10.7	6.4	8.0	2.0	4.4	2.2	0.0	5.8	4.9	0.6	9.6	31.6	316.3	12.3	1.3	0.1	0.1	1.2	18.4	0.2	0.9	1.8	1.5	2.5	1.8	0.0	3.9	23.2	3.7	0.0	0.9	2.0	1.9	2.7	1.8	46.0	4.2	198.3	0.7	0.2	2.7	6.1	0.8	16.5	0.0	0.4	0.7	3.7	0.0	155.0	34.8	2.0	0.6	9.6	2.2	0.9	2.8	0.0	47.8	0.6	14.3	34.0	455.4	5.0	2.6	9.6	0.4	22.4	0.1	4.0	1.3	10.4	2.2	0.0	0.2	0.6	1.0	0.7	0.5	1.3	0.8	35.0	0.0	10.3	0.1
TP53TG5	"C20orf10, CLG01, dJ453C12.5"	ENSG00000124251	"TP53 target 5"	Q9Y2B4	20	45372557-45407889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 17.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 671.5;Late spermatids: 254.4;Oligodendrocytes: 157.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041979, HPA058510, HPA077455"	Enhanced		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA041979: AB_2677778, HPA058510: , HPA077455: "	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-3)"	"unprognostic (3.10e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.72e-5)"	"unprognostic (2.09e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.41e-1)"	0.1	0.1	1.1	0.2	1.8	0.7	0.1	0.9	2.6	0.1	1.4	0.3	0.1	0.2	0.4	0.1	0.2	0.2	0.2	1.1	1.5	0.1	0.1	0.2	0.4	1.8	1.5	0.1	0.1	0.0	0.2	0.1	2.0	0.1	0.0	0.8	0.2	0.0	0.2	0.2	0.2	0.0	0.7	0.2	0.2	17.8	1.7	0.0	0.2	0.0	0.0	0.2	0.1	3.5	0.3	0.7	0.4	1.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.1	0.3	0.3	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.3	0.4	1.0	0.6	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.1	0.0	0.5	0.4	0.3	0.1	0.3	0.3	0.0	0.2	0.2	0.0	0.4	0.4	0.3	1.0	0.4	0.2	0.1	1.1	0.1	0.6	1.4	0.4	0.9	0.2	0.3	0.4	0.0	0.7	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.8	0.9	2.6	1.1	1.5	1.8	1.5	2.0	0.7	1.7	3.5	0.1	0.0	0.0	2.9	0.0	0.1	0.4	0.0	0.0	0.8	0.5	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	671.5	0.5	0.2	0.3	0.0	0.0	7.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.5	0.0	0.0	1.1	254.4	4.7	0.1	0.0	1.9	0.0	0.1	0.0	2.5	157.5	0.0	1.2	4.5	0.0	0.2	0.2	0.1	0.3	1.0	0.0	0.4	1.2	2.1	1.8	0.0	1.1	0.0	0.1	0.0	0.3	0.9
TSPOAP1	"BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1"	ENSG00000005379	"TSPO associated protein 1"	O95153	17	58301228-58328795	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.0;Breast glandular cells: 7.1;Breast myoepithelial cells: 8.1;Collecting duct cells: 7.3;dendritic cells: 22.3;Endometrial ciliated cells: 9.3;Respiratory ciliated cells: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 127.5;HL-60: 52.6;NB-4: 52.6;REH: 99.9;THP-1: 33.0;U-266/70: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024662, HPA025244"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA024662: AB_2066340, HPA025244: AB_1845509"	"unprognostic (2.03e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.23e-4)"	"unprognostic (1.24e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (9.15e-7)"	"unprognostic (1.62e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-2)"	9.7	28.6	71.0	5.6	66.2	40.6	18.4	45.1	92.0	47.3	45.7	35.7	4.0	38.4	6.5	11.0	62.5	5.8	18.1	68.9	47.9	36.6	16.6	18.0	10.8	45.0	49.0	65.9	33.2	14.4	69.9	1.7	44.8	49.1	3.5	17.9	27.7	16.2	8.9	11.8	19.1	6.3	40.2	25.3	26.4	3.7	56.9	13.2	44.9	3.2	5.0	25.0	22.6	52.8	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.0	0.8	0.0	2.8	2.6	0.5	0.0	0.4	0.0	0.0	0.1	127.5	1.1	0.7	1.7	0.0	0.2	52.6	5.1	0.0	0.6	0.0	0.0	12.5	0.0	17.8	2.0	9.3	0.0	0.0	18.1	52.6	0.8	0.0	0.1	99.9	0.0	13.7	0.3	0.1	7.2	4.9	0.2	0.2	0.0	0.1	0.2	33.0	0.0	0.0	1.1	0.2	0.1	36.4	7.2	9.5	0.1	1.6	0.0	0.2	0.0	0.0	1.7	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.3	71.0	66.2	45.1	92.0	68.9	47.9	45.0	49.0	44.8	40.2	56.9	52.8	0.6	9.6	9.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	7.1	8.1	0.0	0.0	4.3	7.3	0.0	0.0	22.3	0.0	1.9	0.9	0.0	9.3	3.1	0.2	0.0	0.0	0.0	0.2	0.7	1.0	0.0	3.7	1.3	4.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.8	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	4.0	0.1	0.0	0.0
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1232.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		63000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	133.7	77.7	60.2	194.5	58.1	150.9	107.8	56.8	65.4	147.1	104.2	200.8	149.1	261.1	91.0	165.1	179.5	117.4	134.2	69.7	69.7	119.4	84.2	142.8	174.6	68.4	69.7	120.5	63.7	89.6	58.4	105.4	68.6	124.5	141.5	93.0	124.9	173.7	94.8	110.4	148.3	214.6	63.1	110.0	131.7	131.9	62.6	188.0	109.8	89.5	149.6	203.0	139.3	68.8	249.5	246.9	213.2	179.4	160.1	265.9	336.9	612.9	561.7	542.9	423.1	296.4	303.3	173.6	193.3	744.4	579.3	158.8	237.3	451.0	582.4	270.7	82.8	494.1	244.6	213.8	377.9	159.4	538.6	256.7	228.4	552.9	276.3	418.7	599.3	301.6	151.6	273.3	540.7	142.8	700.1	229.0	253.4	200.7	250.4	327.8	197.7	146.7	344.9	394.7	72.4	80.5	265.6	141.3	257.3	282.9	120.1	173.9	909.9	415.7	174.6	345.7	548.0	173.4	296.4	225.5	439.7	240.4	522.9	177.4	115.7	213.6	172.3	195.9	134.4	81.6	143.8	173.0	141.4	61.1	145.6	156.9	201.5	129.0	246.9	154.5	214.9	298.4	60.2	58.1	56.8	65.4	69.7	69.7	68.4	69.7	68.6	63.1	62.6	68.8	66.5	35.3	52.9	10.1	77.0	145.3	204.6	103.5	46.7	22.0	65.9	68.7	62.9	52.9	87.4	104.8	41.7	172.5	126.7	347.1	86.1	282.5	500.8	72.2	63.8	103.6	109.2	56.8	4.7	211.3	302.4	68.7	118.3	111.7	82.4	78.7	84.3	71.8	249.2	33.7	8.4	152.6	138.4	159.4	135.8	1232.1	46.9	174.9	80.0	15.0	303.7	82.6	147.2	11.6	9.6	322.8	244.4	92.2	78.3	150.7	169.0	113.1	73.5	28.0	98.6	46.1	168.1	81.6	64.3	74.9	137.0	231.6	132.2	77.2	172.8	193.6
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102028-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.1"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 306.3;Inhibitory neurons: 1019.5;Oligodendrocyte precursor cells: 721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"REH: 2.6;RPTEC TERT1: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	0.1	0.2	7.6	0.5	7.1	0.0	0.0	0.9	8.1	0.3	0.0	1.7	0.2	0.1	0.2	0.5	0.1	0.2	0.7	7.0	2.2	0.1	0.0	0.0	0.4	0.1	2.2	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.6	0.3	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.3	0.1	5.8	0.5	0.0	0.0	0.4	0.3	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.6	7.1	0.9	8.1	7.0	2.2	0.1	2.2	0.0	0.0	5.8	1.1	0.5	9.6	18.7	7.8	0.1	0.4	0.6	0.0	0.6	12.5	0.1	0.3	2.1	0.0	9.3	3.7	35.5	0.1	0.4	0.1	0.0	0.1	0.9	0.6	0.2	2.4	0.0	0.0	306.3	0.9	0.1	2.3	0.0	1.1	0.0	0.2	1.1	0.4	0.1	0.0	1019.5	0.0	0.0	0.0	1.0	0.0	0.0	1.4	8.8	30.0	1.8	0.6	0.0	721.3	9.4	0.4	0.0	0.0	0.4	0.6	0.0	0.1	5.2	1.6	0.0	2.6	0.4	1.1	0.1	0.2	0.9	0.1	0.5	0.1	0.0	0.7
ZNF774	MGC75360	ENSG00000196391	"Zinc finger protein 774"	Q6NX45	15	90352284-90369146	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.0"									"HPA030839, HPA030840"	Uncertain		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Intermediate filaments"	Cytosol	"HPA030839: AB_2673630, HPA030840: AB_10602691"	"unprognostic (1.11e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.89e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.82e-2)"	0.7	2.7	2.3	1.2	4.2	1.0	3.4	4.3	3.6	2.6	0.0	4.6	2.2	2.8	4.1	1.4	3.0	2.9	2.8	1.9	2.6	1.4	1.1	1.1	0.7	0.7	1.0	1.1	3.9	3.1	3.0	0.7	0.8	2.4	7.1	4.0	3.9	5.7	6.2	3.1	2.0	1.8	0.0	0.6	2.6	2.2	2.7	1.5	2.7	7.2	0.9	1.9	1.6	3.3	1.7	0.7	2.1	2.4	0.9	0.5	5.0	1.0	1.7	1.3	1.6	2.7	2.0	0.6	2.0	1.3	3.7	2.5	2.2	3.7	1.3	1.2	4.2	1.8	9.0	1.3	1.6	1.0	1.3	0.5	4.4	1.9	1.8	3.6	2.3	3.4	2.0	0.8	2.1	1.6	1.4	0.9	0.6	4.5	2.5	1.3	1.8	0.5	2.6	4.6	4.8	2.0	2.0	3.1	0.8	2.4	2.1	0.2	1.1	1.4	1.3	1.1	2.2	5.2	3.8	0.4	2.3	2.8	0.7	1.4	0.3	0.7	0.2	0.1	0.1	0.2	0.2	0.3	0.6	0.4	0.2	0.2	1.2	0.7	0.2	0.3	0.1	0.1	2.3	4.2	4.3	3.6	1.9	2.6	0.7	1.0	0.8	0.0	2.7	3.3	0.6	6.4	3.2	0.3	0.7	0.8	2.5	1.0	2.2	6.4	2.4	2.4	4.9	0.0	1.1	0.0	0.0	1.7	0.2	6.8	1.9	2.8	15.4	1.7	2.3	1.0	2.4	0.0	2.5	2.0	1.1	0.9	4.1	3.2	0.0	45.3	0.0	1.5	0.8	8.4	2.3	3.3	0.0	0.3	0.7	11.0	0.3	0.8	0.0	0.0	0.2	2.0	0.0	1.5	1.1	1.7	5.5	2.2	0.7	1.4	1.9	1.1	0.7	5.3	0.0	1.7	1.9	11.8	4.5	1.3	0.3	1.4	0.5	0.3	5.5	2.0